Advertisement

B

  • F. von Bruchhausen
  • S. Ebel
  • A. W. Frahm
  • E. Hackenthal
  • Margitta Albinus
  • Hassan-Fahmy Ali
  • Syed Laik Ali
  • Gudrun Amschler
  • Uwe Amschler
  • Erwin von Angerer
  • Peter Barth
  • Wolfgang Barthel
  • Kurt Bauer
  • Andrea Bauer
  • Jürgen Beckmann
  • Winfried Beil
  • Jürgen Beitz
  • Günther Bellmann
  • Thorsten Beyrich
  • Franz Bossle
  • Helmut Bräunlich
  • Matthias Bräutigam
  • Kerstin Brinkmann
  • Adalbert Brinz
  • Franz von Bruchhausen
  • Kay Brune
  • Axel Büge
  • Ulrich Bürger
  • Wolfram Christ
  • Klaus Daneck
  • Gerd Dannhardt
  • Helga Doering
  • Siegfried Ebel
  • Kurt Eger
  • Peter Emig
  • Thomas Erker
  • Bernhard Feil
  • Monika Fett
  • August Wilhelm Frahm
  • Margarete Frahm
  • Klaus-Jürgen Freundt
  • Wolfram Gaida
  • Detlef Geffken
  • Ulrich Geis
  • Klaus Geldsetzer
  • Ulrich Gessner
  • Erika Glusa
  • Berthold Göber
  • Margarete Goppelt-Strübe
  • Wilhelm Gössling
  • Eberhard Gottwald
  • Beate Grates
  • Annette Graul
  • Sibylle Greiner
  • Adolf Grisk
  • Michael Grosam
  • Jan Gustafsson
  • Hartmut Gustmann
  • Jürgen Haas
  • Axel Haberkorn
  • Eberhard Hackenthal
  • Annette Häfner
  • Boris Haluszczynski
  • Achim Harder
  • Susanne Hartmann
  • Heribert Häusler
  • Marcus Heidenreich
  • Gerhard Heinemeyer
  • Bernd Hempel
  • Monika Herboth
  • Klaus Herbrand
  • Sibylle Hoedt-Schmidt
  • Wolfgang Hoefke
  • Hermann Hoffmann
  • Ute Hoffmann-Schollmayer
  • Bernhard Hofmann
  • Ulrike Holzgrabe
  • Anette Hornberger
  • Ute Hübner-Steiner
  • Martin Hug
  • Wolfgang Ibrom
  • Walter Janßen
  • Angela Jördens
  • Ilmar Jurna
  • Günther Kaiser
  • Dieter-Abbo Kalbhen
  • Petra Kisser
  • Christoph Klett
  • Stephanie Klett
  • Gerd Kobal
  • Johannes Koehler
  • Axel Kramer
  • Birgit Krammer
  • Gottfried Kreutz
  • Reinhard Kroker
  • Markus Kuhn
  • Norbert Kühn
  • Dorothea Landsiedel
  • Andreas Langner
  • Martina Laudszun
  • Jochen Lehmann
  • Marion Sylvia Lehner
  • Stefan Leiner
  • Hans Löwe
  • Johannes Mann
  • Detlef Manns
  • Wolfgang Matthiessen
  • Rainer Maue
  • Peter Maul
  • Andreas Maurer
  • Ralf Mayer
  • Wolfgang Meindl
  • Werner Meise
  • Klaus Menges
  • Paul Messinger
  • Hans-Jürgen Mest
  • Frank Peter Meyer
  • J. Mollière
  • Rudolf Morgenstern
  • Wolfgang Morick
  • Joachim Mössner
  • Alfred Müller
  • Walter E. Müller
  • Klaus Müller
  • Christa Müller
  • Daniel Müller
  • Michael Neugebauer
  • Ottmar Neugebauer
  • Peter Nickel
  • Peter Nuhn
  • Bernd Nürnberg
  • Joachim Oertel
  • Michael Oettel
  • Tilmann Ott
  • Thomas Otzen
  • Hartmut Oßwald
  • Peter Pachaly
  • Helmut Pelzer
  • Karl-Uwe Petersen
  • Siegfried Pfeifer
  • Klaus Pietrzik
  • Kathrin Pöllath
  • Olaf Queckenberg
  • Bernd Raffelsberger
  • Eberhard Reimann
  • Jörg Remien
  • Markus Reuß
  • Andreas Reymann
  • Joachim Richter
  • Peter H. Richter
  • Hubert Richter
  • Klaus Rittinghaus
  • Hans Rommelspacher
  • Gerhard Rücker
  • Gerhard Schaefer
  • Klaus Schaefer
  • Jutta Schcerer
  • Helmut Schlager
  • Hildegard Schleinitz
  • Wolfgang Schlichter
  • Gerhard Schmidt
  • Wolfgang Schmutzler
  • Johannes Schräder
  • Thomas Schulz-Schalge
  • Harald Schütz
  • Helmut Schwilden
  • Gisela Skopp
  • Ulrich Speck
  • Marcus Spohn
  • Ralf Stahlmann
  • Johannes-Peter Stasch
  • E. Staubli
  • Jürgen Steinmeyer
  • Karl-Heinz Stiefvater
  • Michael Streek
  • Günther Strippel
  • Karl-Heinz Surborg
  • Ulf Sürig
  • Istvan Szelenyi
  • Alfred Thomas
  • Herbert Trampisch
  • Reinhard Troschütz
  • Bernard Unterhalt
  • Eugen J. Verspohl
  • Sabine Vogel
  • Franz-Josef Volk
  • Sven Völkl
  • Heinz Walther
  • Horst Weber
  • Martin Wenzel
  • Marion Weyandt-Spangenberg
  • Sandra Wich
  • Burkhard Wichert
  • Hilke Winterhoff
  • Peter Witte
  • Monika Wolff

References

  1. 1.
    Magni L, Sjöberg B, Sjövall I, Wessmann I (1976) Clinical pharmacological studies with bacampicillin. In: Williams ID, Geddes AM (Hrsg.) Chemotherapy, Bd.5, Penicillins and Cephalosporins, Plenum Publishing Corporation, New York, S. 109–114CrossRefGoogle Scholar
  2. 2.
    Bergan T (1978) Antimicrob Agents Chemother 13:971–974PubMedCrossRefGoogle Scholar
  3. 3.
    Ehrnebo M, Nilsson SO, Boreus LO (1979) J Pharmacokin Biopharm 7:429–451CrossRefGoogle Scholar
  4. 4.
    Ekström B, Müller G (1985) Entwicklung der Penicillinester. In: Adam D, Grobecker H, Naber KG (Hrsg.) Das Jahrhundert der Penicilline, FAC (Fortschritte der Antimikrobiellen und Antineoplastischen Chemotherapie) 4–6:1.245–1.256 F CWGoogle Scholar

References

  1. 1.
    Ikeda S, Sakamoto F, Kondo H, Moriyama M, Tsukamoto G (1984) Chem Pharm Bull 32:4316–4322CrossRefGoogle Scholar
  2. 2.
    Van Schepdael A, Roets E, Hoogmartens J, Vanderhaeghe H (1986) J Chromatogr 370:149–156CrossRefGoogle Scholar
  3. 3.
    HeintzB, Krüger M (1985) Dtsche Apoth Ztg 49:2594–2602Google Scholar
  4. 4.
    Sakamoto F, Ikeda S, Tsukamoto G (1984) Chem Pharm Bull 32:2241–2248PubMedCrossRefGoogle Scholar

IW

  1. 1.
    Siewert G, Strominger JL (1967) Proc Natl Acad Sci USA 57:767–773PubMedCrossRefGoogle Scholar
  2. 2.
    Popov N (1982) Z Ärztl Fortbild 76:624–633Google Scholar
  3. 3.
    Reynolds JEF (1982) Martindale. The extra pharmacopoeia, Pharmaceutical Press, London, S. 1100Google Scholar
  4. 4.
    Keller H, Follath F (1988) Miscellaneous antibiotics. In: Dukes MNG (Hrsg.) Meyler’s side effects of drugs, Elsevier, Amsterdam New York Oxford, S. 543–566Google Scholar
  5. 5.
    Kiser JS (1984) Subtherapeutic uses of antibiotics and sulfonamides in animal agriculture. In: Steele JH, Beran GW (Hrsg.) Handbook series in Zoonoses, CRC Press, Boca Raton, Florida, S. 81–107Google Scholar

fm

  1. 1.
    Baum M, Schuster F (1988) Pharm Ztg 133, 17:28–32Google Scholar
  2. 2.
    Ushimaru F, Sato M, Kosasayama E, Shimizu M, Takashi H (Daiichi Seiyaku Co., Ltd.) Japan. Pat. 7016,692 (1970, 1966), zit. nach CA (1970) 73:77167wGoogle Scholar
  3. 3.
    Keberle H, Faigle JW, Wühelm M (CIBA Ltd.) Schw. Pat. 449,046 (1968, 1963), zit. nach CA (1968) 69:106273fGoogle Scholar
  4. 4.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1968) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, LondonGoogle Scholar

MW

  1. 1.
    Davidoff RA (1985) Ann Neurol 17:107–116PubMedCrossRefGoogle Scholar
  2. 2.
    Delwaide PJ (1985) Ann Neurol 17:90–95PubMedCrossRefGoogle Scholar
  3. 3.
    Bowery NG (1982) Trends Pharmacol Sci 3:400–403CrossRefGoogle Scholar
  4. 4.
    Potashner SJ (1978) Can J Physiol Pharmacol 56:150–156PubMedCrossRefGoogle Scholar
  5. 5.
    Haaß A (1989) Pharmakotherapie der Spastizität. In: Grünninger W (Hrsg.) Spinale Spastik, Ueberreuter Wissenschaft, Wien Berlin, S. 33–49Google Scholar
  6. 6.
    Jones RF, Lance JW (1976) Med J Austr 63:654–657Google Scholar
  7. 7.
    Stien R, Nordal HJ, Oftedal SI, Slettebo M (1987) Acta Neurol Scand 75:190–194PubMedCrossRefGoogle Scholar
  8. 8.
    Bass B, Weinshenke BN, Rice GPA, Noseworthy JH, Camerin MGP, Hader W, Bouchard S, Ebers GC (1988) Can J Neurol Sci 15:15–19PubMedGoogle Scholar
  9. 9.
    Pellkofer M, Paulig M (1989) Med Klinik 84:5–8Google Scholar
  10. 10.
    Bayerl Jr., Gruia D (1985) Therapiewoche 35:5.440–5.444Google Scholar
  11. 11.
    Newman PM, Nogues M, Newman PK, Weightman D, Hudgson P (1982) Eur J Clin Pharmacol 23:31–35PubMedCrossRefGoogle Scholar
  12. 12.
    Hoogstraten MC, van der Ploeg RJO, van der Brug W, Vreeling A, van Marie S, Minderhoud JM (1988) Acta Neurol Scand 77:224–230PubMedCrossRefGoogle Scholar
  13. 13.
    Smolenski Ch, Muff S, Smolenski-Kautz S (1981) Curr Med Res Opinion 7:374–383Google Scholar
  14. 14.
    Benecke R, Noth J (1986) Nervenheilkunde 5:106–114Google Scholar
  15. 15.
    Henning K, Edelmann P (1972) Med Welt 23:203–205PubMedGoogle Scholar
  16. 16.
    Zalman E (1976) Ärztl Praxis 28:2.435–2.438Google Scholar
  17. 17.
    Hassan N, McLelan DL (1980) J Neurol Neurosurg Psychiat 43:1.132–1.136CrossRefGoogle Scholar
  18. 18.
    Simpson GM, Lee JH, Shrivastava RK, Branchey MH (1978) Psychopharmacol 14:16–18Google Scholar
  19. 19.
    Fromm GH (1989) Clin Neuropharmacol 12:185–194PubMedCrossRefGoogle Scholar
  20. 20.
    Fromm GH (1990) Neurol Clin 8:143–151PubMedGoogle Scholar
  21. 21.
    Wuis EW, Dirks MJM, Termond EFS, Vree TB, van der Kleijn E (1989) Eur J Clin Pharmacol 37:181–184PubMedCrossRefGoogle Scholar
  22. 22.
    Peterson GM, McLean S, Milligen KS (1985) Med J Austr 42:689–690Google Scholar
  23. 23.
    Kochak GM, Rakhit A, Wagner WE, Hone F, Waldes L, Kershaw RA (1985) Clin Pharmacol Ther 38:251–257PubMedCrossRefGoogle Scholar
  24. 24.
    Dahlin PA, George J (1984) Drug Intell Clin Pharm 18:805–808PubMedGoogle Scholar
  25. 25.
    Hulme A, Maclennan WJ, Ritchie RT, John VA, Shatton PA (1984) Eur J Clin Pharmacol 29:467–469CrossRefGoogle Scholar
  26. 26.
    Terrence CF, Fromm GH (1981) Arch Neurol 38:588–589PubMedCrossRefGoogle Scholar

EH

  1. 1.
    Sakanashi M, Hiraki I (1979) Jap J Pharmacol 29:125–131PubMedCrossRefGoogle Scholar
  2. 2.
    Marmo E, Saini RK, Caputi AP (1974) Res Commun Chem Pathol Pharmacol 8:247–272PubMedGoogle Scholar
  3. 3.
    Weidinger H, Kirchner F, Holm E, Boettger F (1970) Arzneim Forsch 20(Suppl 11a):1.964–1.968Google Scholar
  4. 4.
    Hiratsuka K, Wakabayashi K, Mayahara T, Yamada S (1974) Nippon Yakurigaku Zasshi 70:199–205PubMedCrossRefGoogle Scholar
  5. 5.
    Hauschild F, Modersohn D (1967) Acta Biol Med Ger 18:725–732PubMedGoogle Scholar
  6. 6.
    De Ritis G, Vittore F (1974) Clin Ther 69:341–352Google Scholar
  7. 7.
    Meilander S (1966) Angiologika 3:77–99Google Scholar
  8. 8.
    Kovach AG, Szentagothai K, Hamar J, Dora E, Nyary I (1970) Arzneim Forsch 20(Suppl Ha): 1.659Google Scholar
  9. 9.
    Monzeeglio C, Panzarasa R (1974) Farmaco Prat 29:192–197Google Scholar
  10. 10.
    Fedina L, Kovach AG, Huszar V (1970) Arzneim Forsch 20(Suppl lla):1.656Google Scholar
  11. 11.
    MAR29,S. 1.493Google Scholar
  12. 12.
    Benzi G, Arrigoni E, Pastoris O, Villa R (1976) Farmaco Sci 31:3–20PubMedGoogle Scholar
  13. 13.
    Benzi G, Panceri P, De Bernardi M, Villa R, Arcelli E, D’Angelo L, Arrigoni E, Berte F (1975) J Appl Physiol 38:565–569PubMedGoogle Scholar
  14. 14.
    Hengstmann JH, Steinkamp B (1981) Arzneim Forsch 31:843–884Google Scholar
  15. 15.
    Koster AS, Feankhuijzen-Sierevogel AC, Noordhoek J (1985) Drug Metab Dispos 13:232–238PubMedGoogle Scholar
  16. 16.
    Johansson BW (1969) Nord Med 81:660–668PubMedGoogle Scholar
  17. 17.
    Rausch KD (1975) Z Allgemeinmed 51:290–291PubMedGoogle Scholar
  18. 18.
    Nobbe F (1974) Z Allgemeinmed 50:957–964PubMedGoogle Scholar
  19. 19.
    Janssen W (1970) Med Monatsschr 24:471–472Google Scholar
  20. 20.
    Corrigan Jr., Langerman MJ, Moore ML (1945) J Am Chem Soc 67:1.894–1.896CrossRefGoogle Scholar
  21. 21.
    Kikugawa K, Kato T, Takeda Y (1987) Mutat Res 177:35–13PubMedCrossRefGoogle Scholar
  22. 22.
    Furihata C, Yamakoshi A, Matsushima T, Kato T, Kikugawa K (1988) 3:299–301Google Scholar

KC

  1. 1.
    Dibbern H W, (1978), UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor AulendorfGoogle Scholar
  2. 2.
    Unveröffentliche Ergebnisse der Firma Boehringer IngelheimGoogle Scholar

HÄ/pb

  1. 1.
    BE 602888 (1961) zit. nach CA (1962) 56:5981Google Scholar
  2. 2.
    DE 3120909 (1981) corcordant mit FR 2483922, zit. nach CA (1982) 96:199432Google Scholar
  3. 3.
    Moffat AC Clarke’s Isolation and Identification of Drugs, 2.Aufl., The Pharmaceutical Press London 1986, S. 371Google Scholar
  4. 4.
    Hansch C, Sammes PG, Taylor JB Comprehensive Medicinal Chemistry Pergamon Press, Oxford 1990 Bd 6, S.296Google Scholar
  5. 5.
    Etienne J, Taelman H (1976) Clin Chim Acta 69:147–149PubMedCrossRefGoogle Scholar
  6. 6.
    Carlucci G, Colanzi A, Mazzeo P (1990) J Pharm Biomed Anal 8:1067–1069PubMedCrossRefGoogle Scholar
  7. 7.
    Belliardo F, Lucarelli C (1990) J Chromatogr 535:305–309PubMedCrossRefGoogle Scholar
  8. 8.
    Schiantarelli P, Acerbi D, Botta G C, Bonati L, Capelli P, Rondelli I (1989) Arzneim Forsch 39:215–219Google Scholar
  9. 9.
    Donion L, Dusart P, Temmerman P (1969) Arzneim Forsch 19:785–789Google Scholar
  10. 10.
    Nicot G, Lachatre G, Gonnet C, Rocca J L, Valette J P, Merle L, Nouaille Y (1983) J Chromatogr 277:239–249PubMedGoogle Scholar
  11. 11.
    Jambut-Absil A C, Buxeraud J, Claude J, Raby C (1987) Arzneim Forsch 37:772–777Google Scholar

Ba

  1. 1.
    Mar 29, S. 1.522Google Scholar

vB

  1. 1.
    Knoll AG (1949), DBP903213, zit. nach CA (1955) 49:6318gGoogle Scholar
  2. 2.
    Beilsteins Handbuch der Organischen Chemie E III/IV 22:3753, System-Nr. 3390Google Scholar
  3. 3.
    Testa B, Murset-Rossetti (1978) Helv Chim Acta 61:2530–2537CrossRefGoogle Scholar
  4. 4.
    Auterhoff H, Kovar KA (1985) Identifizierung von Arzneistoffen, 5. Aufl., Wissenschaftusche Verlagsgesellschaft, StuttgartGoogle Scholar
  5. 5.
    Beilsteins Handbuch der Organischen Chemie EV 22/8:36, Springer-Verlag, BerlinGoogle Scholar

MP

  1. 1.
    Mar 29, S. 446Google Scholar
  2. 2.
    Neidlein VR, Kleiser M (1987) Arzneimittelforsch 37:174–177PubMedGoogle Scholar
  3. 3.
    Neidlein R, Kleiser M (1987) Arzneimittelforsch 37:337–339PubMedGoogle Scholar

EH

  1. 1.
    Suranyl L (Knoll AG) DBP, S. 1, 120, 452 (Anmeldung 16.4.1960), zit. nach CA (1962). 56:10298Google Scholar

PA

  1. 1.
    Dick RW, Mitchell CI (1967) Arch Int Pharmacodyn Ther 170:333–342PubMedGoogle Scholar
  2. 2.
    Bretas AD, Lemos Neto M de (1983) Arq Neuropsiquiatr 41:356–366PubMedCrossRefGoogle Scholar
  3. 3.
    Iven H, Feldbusch E (1983) Arch Pharmacol 324:153–159CrossRefGoogle Scholar
  4. 4.
    Perucca E, Grimaldi R, Ruberto G, Gelmi C, Trimarchi F, Crema A (1986) Eur J Clin Pharmacol 29:729–730PubMedCrossRefGoogle Scholar
  5. 5.
    Bragatti JH, Caleffi GH, Prenna FJ (1977) Arq Neuropsiquiatr 35:277–281PubMedCrossRefGoogle Scholar
  6. 6.
    Reis TT, Maia Filho PC, Cechini PC (1980) Arq Neuropsiquiatr 38:93–98PubMedCrossRefGoogle Scholar
  7. 7.
    Borromei A, Caramelli R, Cipriani G, Giancola LC, Guerra L, Lozito A (1987) Minerva Med 78:1687–1705PubMedGoogle Scholar
  8. 8.
    Visintini D, Calzetti S, Mancia D (1981) Riv Patol Nerv Ment 102:29–37PubMedGoogle Scholar
  9. 9.
    Marshden P, Sheldon J (1972) Brit Med J 1:730CrossRefGoogle Scholar

Hg

  1. 1.
    Komori S (1975) Japan 7.537,673; CA (1976) 85:108659Google Scholar
  2. 2.
    Kuhnert-Brandstätter M, Bachleitner-Hofmann F (1971) Arch Pharm 304:580CrossRefGoogle Scholar
  3. 3.
    Fischer E, Dilthey A (1904) Liebigs Ann Chem 335:338Google Scholar
  4. 4.
    Nelville GA, Cook D (1969) Can J Chem 47:743CrossRefGoogle Scholar
  5. 4a.
    Nelville GA,Avdovich HW, By AW (1970) Can J Chem 48:2274CrossRefGoogle Scholar
  6. 5.
    Rücker G (1966) Arch Pharm 299:688CrossRefGoogle Scholar
  7. 6.
    Okada J, Esaki T (1974) Chem Pharm Bull 22:1580PubMedCrossRefGoogle Scholar
  8. Asada S, Nishijo J (1978) Bull. Chem Soc Jp 51:3379CrossRefGoogle Scholar
  9. 7.
    Poetke W, Fürst W (1959) Pharm Zentralh 98:171Google Scholar

RE

  1. 1.
    Harvey SC (1975) Hypnotics and sedatives. The barbiturates. In: Goodman LS, Gilman A, Gilman AG, Koelle GB (Eds.) The pharmacological basis of therapeutics, 5th ed., MacMillan Publ., New York Toronto London, p. 102–123Google Scholar
  2. 2.
    Varin F, Marchand C, Larochelle P, Midha KK (1980) J Pharm Sci 69:640–643PubMedCrossRefGoogle Scholar
  3. 3.
    Kaneniwa N, Hiura M, Funaki T (1985) Int J Pharm 26:157–164CrossRefGoogle Scholar
  4. 4.
    Wellhöner HH (1990) Allgemeine und systemtatische Pharmakologie und Toxikologie, 5. Aufl., Springer, Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona, S. 348–353CrossRefGoogle Scholar
  5. 5.
    Ellenhorn JM, Barceloux DG (1988) Medical Toxicology. Diagnosis and treatment of human poisoning, Elsevier, New York Amsterdam London, p. 575–586Google Scholar
  6. 6.
    Johanson CE, Woodbury DM (1977) Exp Brain Res 30:65–74PubMedCrossRefGoogle Scholar
  7. 7.
    Persaud TV, Henderson WM (1969) Arzneim Forsch 19:1309–1310Google Scholar
  8. 8.
    Bailey DN, Jatlow PI (1975) Am J Clin Pathol 64:291–296PubMedGoogle Scholar
  9. 9.
    Wilbrandt W (1964) Schweiz Med Wschr 94:737–745PubMedGoogle Scholar
  10. 10.
    Ching M (1981) J Endocrinol Invest 4:389–392PubMedGoogle Scholar
  11. 11.
    Lin SC, Sutherland VC (1977) Res Commun Chem Pathol Pharmacol 18:215–231PubMedGoogle Scholar
  12. 12.
    Ho IK, Harris RA (1981) Ann Rev Pharmacol Toxicol 21:83–111CrossRefGoogle Scholar
  13. 13.
    Turnbull MJ, Watkins JW (1976) Eur J Pharmacol 36:15–20PubMedCrossRefGoogle Scholar
  14. 14.
    Fischer E, Gregus Z, Varga F (1980) Digestion 20:115–120PubMedCrossRefGoogle Scholar
  15. 15.
    Matsuyama K, Kado K, Nishiuchi M, Goromaru T, Tsuzuki O, Noda A, Iguchi S (1981) J Pharmacobiodyn 4:28–34PubMedCrossRefGoogle Scholar
  16. 16.
    Morgan WW, Grant RW (1976) Eur J Pharmacol 40:349–357PubMedCrossRefGoogle Scholar
  17. 17.
    Aeschbacher HU, Atkinson J, Domahidy B (1975) J Pharmacol Exp Ther 192:635–641PubMedGoogle Scholar
  18. 18.
    Bansinath M, Bose AC, Hema S, Guruswami MN (1982) Arch Int Pharmacodyn Ther 260:14–27PubMedGoogle Scholar
  19. 19.
    Adaudi AO, Oheme FW (1981) Clin Toxicol 18:1105–1115PubMedCrossRefGoogle Scholar

Hg

  1. 1.
    Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, AulendorfGoogle Scholar

RE

  1. 1.
    BAz, Nr. 109a vom 16.06.1987Google Scholar
  2. 1.
    BAz, Nr. 190a vom 10.10.1985 i.d.F. vom BAz, Nr. 130 vom 17.07.1991Google Scholar

GS

  1. 1.
    BAz, Nr. 190a vom 10.10.1985 i. d. F. Nr. 130 vom 17.07. 1991Google Scholar

GS

  1. 1.
    Simoleit H, Walter L, Jäger P, Riechers HH, Wagner H (1985) Barium and Barium Compounds. In: Gerhartz W (Hrsg.) Ullmann’s Encyclopedia of Industrial Chemistry, 5. Aufl, Bd A3, VCH Verlagsgesellschaft, Weinheim, S.330ffGoogle Scholar

WS

  1. 1.
    Hecht G (1939) Röntgenkontrastmittel. In: Handbuch d. exper. Pharmakologie, Ergänzungswerk, Springer, Berlin, 8:79–163CrossRefGoogle Scholar
  2. 2.
    Brown GR (1963) Radiol 81:839–846Google Scholar
  3. 3.
    Treicher J (1977) Fortschr Röntgenstr 127,4:308–314CrossRefGoogle Scholar
  4. 4.
    Toischer HP (1983) Fortschr Röntgenstr 139,1:21–24CrossRefGoogle Scholar
  5. 5.
    Clavel JP, Lorillot ML, Buthan D, Gerbet D, Heitz F, Galli A (1987) Therapie 42:232–243Google Scholar
  6. 6.
    Barke R (1970) Röntgenkontrastmittel, Thieme, Leipzig, S. 195–199Google Scholar
  7. 7.
    Feczko PJ, Simms SM, Bakirci N (1989) AJr. 153:275–276 USPubMedCrossRefGoogle Scholar
  8. 1.
    VEB Chemische Werke Radebeul (1961) Ger 1.100.639, zit. nach CA (1962) 56:14.409cGoogle Scholar
  9. 2.
    Kretschmer P (1986) Zentralbl Pharm 125:575–579Google Scholar
  10. 1.
    Femmer K, Nowak R (1964) Pharmazie 19:762–767PubMedGoogle Scholar

gs

  1. 1.
    Stocker K, Barlow GH (1976) Methods Enzymol 45:214–223PubMedCrossRefGoogle Scholar

WE

  1. 1.
    Aronson DL (1976) Thromb Haemost 36:9–13PubMedGoogle Scholar
  2. 2.
    Stocker K, Fischer H, Meier J (1982) Toxicon 20:265–273PubMedCrossRefGoogle Scholar
  3. 3.
    Itoh N, Tanaka N, Mihashi S, Yamashina I (1987) J Biol Chem 262:3.132–3.135Google Scholar
  4. 4.
    Weisel JW (1986) Biophys J 50:1.079–1.093CrossRefGoogle Scholar
  5. 5.
    Olexa SA, Budzynski AZ (1980) Biochemistry 19:647–651PubMedCrossRefGoogle Scholar
  6. 6.
    Glusa E, Brauns H, Stocker K (1991) Toxicon 29:725–732PubMedCrossRefGoogle Scholar
  7. 7.
    Walter M, Nyman D, Krajnc V, Duckert F (1977y) Thromb Haemost 38:438–446PubMedGoogle Scholar
  8. 8.
    Klocking HP, Markwardt F, Guttner J (1989) Pharmazie 44:504–505PubMedGoogle Scholar
  9. 9.
    Klocking HP, Hoffmann A, Markwardt F (1987) Haemostasis 17:235–237PubMedGoogle Scholar
  10. 10.
    Shibuya M, Niitani H, Aoyama A, Kawachi S, Nukariya N, Baba M, Iizuka K, Sakai S, Ohtsuka M (1990) J Cancer Res Clin Oncol 116:168–172PubMedCrossRefGoogle Scholar
  11. 11.
    Chmielewska J, Poggi A, Janik P, Latallo ZS, Donati MB (1980) Eur J Cancer 16:919–923PubMedGoogle Scholar
  12. 12.
    Anaclerio A, Ruggeri A, Poggi A, Spreafico F, Donati MB (1980) Thromb Res 18:253–258PubMedCrossRefGoogle Scholar
  13. 13.
    Sugai K, Imamura Y, Mihashi S, Mori N, Baba S (1986) J Toxicol Sci 11:155–167PubMedCrossRefGoogle Scholar
  14. 14.
    Sugai K, Imamura Y, Mihashi S, Ohba M, Kunikane K, Mori N, Baba S 81986) J Toxicol Sci 11:135–143Google Scholar
  15. 15.
    Nasu Y (1986) Scand J Work Environ Health 12:272–276PubMedCrossRefGoogle Scholar
  16. 16.
    Bruning H, Christophers E (1991) Hautarzt 42:227–232PubMedGoogle Scholar
  17. 17.
    Katzel R, Lutze G, Seile B, Gutwasser H (1991) Z Gesamte Inn Med 46:708–711PubMedGoogle Scholar
  18. 18.
    Becker U, Bartl K, Wahlefeld AW (1984) Thromb Res 35:475–484PubMedCrossRefGoogle Scholar

EH

  1. 1.
    Cassel RT, KushnerS (American Cyanamid) US Patent, 2, 569, 288, (ert. 1951, Prior. 1949), zit. nach CA (1952)46:3565cGoogle Scholar
  2. 2.
    Kushner C, Cassel JM, Williams JH (1951) J Org Chem 16:1283CrossRefGoogle Scholar
  3. 3.
    Clarke CGC (Hrsg.) (1969/1975) Isolation and Identification of Drugs, Pharmaceutical Press, LondonGoogle Scholar
  4. 4.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, LondonGoogle Scholar

PA

  1. 1.
    Mar 29, S. 400Google Scholar

vB

  1. 1.
    Svedmyr N (1982) Eur J Resp Dis 63 S122:48–53Google Scholar
  2. 2.
    Kaiser H (1987) Thieme, Stuttgart New YorkGoogle Scholar
  3. 3.
    Schleimer RP (1985) Ann Rev Pharmacol Toxicol 25:381–412CrossRefGoogle Scholar
  4. 4.
    Hahn HL (1990) Wirkungsmechanismen der Glukokortikoide bei Asthma, bronchialer Entzündungsreaktion und Hyperreaktivität. In: Nolte D (Hrsg.) Glukokortikoide bei obstruktiven Atemwegserkrankungen, de Gruyter, Berlin New York, S. 23–56Google Scholar
  5. 5.
    Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:2–10CrossRefGoogle Scholar
  6. 6.
    Schleimer RP (1990) Am Rev Respir dis 141 S2:59–69Google Scholar
  7. 7.
    Williams TJ, Yarwood H (1990) Am Rev Respir Dis 141 S2:39–43CrossRefGoogle Scholar
  8. 8.
    Barnes PJ (1990) Am Rev Respir Dis 141 S2:70–76CrossRefGoogle Scholar
  9. 9.
    Lundgren JD, Kaliner MA, Shelhamer JH (1990) Am Rev Respir Dis 141 S2:52–57Google Scholar
  10. 10.
    Svedmyr N (1990) Am Rev Respir Dis 141 S2:31–38Google Scholar
  11. 11.
    Check WA, Kaliner MA (1990) Am Rev Respir Dis 141 S2:44–51Google Scholar
  12. 12.
    Möllmann HW, Barth J, Schott D, Ulmer WT, Derendorf H, Hochhaus G (1989) Intensivmed 26:2–15Google Scholar
  13. 13.
    Johansson SA, Andersson KE, Brattsand R, Gruvstad E, Hedner P (1982) Eur J Clin Pharmacol 22:523–529PubMedCrossRefGoogle Scholar
  14. 14.
    Martin LE, Harrison C, Tanner RJN (1975) Postgrad Med J 51:11–20PubMedGoogle Scholar
  15. 15.
    Martin LE, Tanner RJN, Clark THJ, Cochrane GM (1974) Clin Pharmacol Ther 15:267–275PubMedGoogle Scholar
  16. 16.
    Toogood JH (1990) Am Rev Respir Dis 141 S2:89–96CrossRefGoogle Scholar
  17. 17.
    Ellul-Micallef R (1982) Eur J Respir Dis 63 S122:118–125Google Scholar
  18. 18.
    Andersson P, Ryrfeldt A (1984) J Pharm Pharmacol 36:763–765PubMedCrossRefGoogle Scholar
  19. 19.
    Brogden RN, Heel RC, Speight TM, Avery GS (1984) Drugs 28:99–126PubMedCrossRefGoogle Scholar
  20. 20.
    Reed CE (1990) Am Rev Respir Dis 141 S2:82–88Google Scholar
  21. 21.
    Kaiser H (1980) Dtsch Med Wochenschr 105:1.329–1.332CrossRefGoogle Scholar
  22. 22.
    Smith MJ (1987) Drugs 33:423–429PubMedCrossRefGoogle Scholar
  23. 23.
    Mygind N, Clark TJH (1980) Safety and topical side effects. In: Mygind N, Clark TJH (Hrsg.) Topical treatment for asthma and rhinitis, Baillere-Tindall, London, S. 171–179Google Scholar
  24. 24.
    Stead J, Cooke NJ (1989) Brit Med J 298:403–404PubMedCrossRefGoogle Scholar
  25. 25.
    Chen-Waiden H, Wendt H (1981) The effect of beclomethasone dipropionate (BDP) and fluocortin-butylester (FCB), inhaled in high doses on the adrenal function in healthy volunteers. In: Chen-Waiden H, Wendt H (Hrsg.) Fluocortinbutylester-a new inhalable corticosteroid for the treatment of asthma and rhinitis, Hof garten, Berlin, S. 3.1–3.5Google Scholar
  26. 26.
    Sherman BM (1981) A comparison of the effects of beclomethasone dipropionate and fluocortinbutylester on pituitary-adrenal function in healthy adults. In: Chen-Walden H, Wendt H (Hrsg.) Fluocortinbutylester-a new inhalable corticosteroid for the treatment of asthma and rhinitis, Hofgarten, Berlin, S. 4.1–4.4Google Scholar
  27. 27.
    Weinberger M (1982) Eur J Resp Dis 63 S122:243–251Google Scholar
  28. 28.
    Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G (1986) Br Med J 293:1.463–1.466Google Scholar

GM

  1. 1.
    Merte HJ, Stryz Jr. (1984) Klin Monatsbl Augenheilkd 184:55–58PubMedCrossRefGoogle Scholar
  2. 2.
    Merte HJ, Stryz Jr. (1984) Klin Monatsbl Augenheilkd 184:316–317PubMedCrossRefGoogle Scholar
  3. 3.
    Hoh H (1990) Klin Monatsbl Augenheilkd 196:219–224PubMedCrossRefGoogle Scholar
  4. 4.
    Dorigo MT, Cerin O, Fracasso G, Altafini R (1990) Int J Clin Pharmacol Res 10:163–166PubMedGoogle Scholar

PH

  1. 1.
    Nakano J, Mimura M, Hayashida M, Kazuhiko K, Nakanishi T (1983) Heterocycles 20:1975–1978CrossRefGoogle Scholar

ME

  1. 1.
    Benica WS, Wilson CO (1950) J Am Pharm Assoc 39:451Google Scholar
  2. 2.
    Thole FB, Thorpe JF (1911) J Chem Soc 99:439Google Scholar
  3. 3.
    Gänshirt H (1967). In Stahl E (Hrsg.) Dünnschichtchromatographie, 2. Aufl., Springer Verlag, Berlin Heidelberg New YorkGoogle Scholar

MA

  1. 1.
    Mar 29, S. 1.439Google Scholar

vB

  1. 1.
    Mar 29, Bemetizide 978Google Scholar
  2. 2.
    Humpert U (1990) Therapiewoche 31:309–312Google Scholar
  3. 3.
    Loew D (1990) Pharmakokinetik der Diuretika. In: Loew D, Heimsoth V, Kuntz E, Schilcher H (Hrsg.), Diuretika, Thieme, Stuttgart, New York, S. 101–121Google Scholar
  4. 4.
    Chasseaud LF (1977) Angiologie 16:43–48Google Scholar
  5. 5.
    Brodie RR, Chasseaud LF, Darragh A, Taylor T, Walmsly LM (1982) Biopharmaceut Drug Dispos 3:361–370CrossRefGoogle Scholar

Oß/al

  1. 1.
    Ciba AG, Schw. Pat. 183, 065 (1936, 1934); CA (1936) 30:85316.Google Scholar
  2. 2.
    Hill AJ, Holmes RB (American Cyanamid Co.), U.S.Pat. 2, 394, 770 (1946, 1942); CA (1946) 40:31414.Google Scholar
  3. 3.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs. Pharmaceutical Press, London.Google Scholar

ME

  1. 1.
    Witkin JM, Gordon RK, Chiang PK (1987) J Pharmacol Exp Ther 242:796–803PubMedGoogle Scholar
  2. 2.
    Rogers GA, Parsons SM (1989) Mol Pharmacol 36:333–341PubMedGoogle Scholar
  3. 3.
    Domino EF (1971) Antianxiety Drugs. In: Di Palma Jr. (Hrsg.) Drill’s Pharmacology in Medicine, 4. Aufl., McGraw-Hill Book Company, New York, S. 495–497Google Scholar
  4. 4.
    Harris LW, Stitcher DL, Heyl WC (1980) Life Sci 26:1.885–1.891CrossRefGoogle Scholar
  5. 5.
    Penetar DM (1985) Psychopharmacology (Berlin) 87:69–76CrossRefGoogle Scholar
  6. 6.
    Dlabac A (1973) Acta Nerv Super 15:133–136Google Scholar
  7. 7.
    Farrer DM, Yochmowitz MG, Mattsson JL, Lof NE, Bennett CT (1982) Pharmacol Biochem Behav 16:605–609PubMedCrossRefGoogle Scholar
  8. 8.
    Mukai T (1983) Pharmacobio-Dyn 6:301–308CrossRefGoogle Scholar
  9. 9.
    Kumada S, Otsuka M (1970) Nippon Yakubutsugaku Zasshi 66:600–606CrossRefGoogle Scholar
  10. 10.
    Sunagane N, Sakata T, Uruno T, Kubota K (1983) J Pharmacobiodyn 6:466–474PubMedCrossRefGoogle Scholar
  11. 11.
    Mar 29 (714)Google Scholar
  12. 12.
    Mukai T, Tagaki K (1983) Nippon Heikatsukin Gakkai Zhassi 19:97–105CrossRefGoogle Scholar
  13. 13.
    Edelson J, Schlosser A, Douglas JF (1970) Arch Int Pharmacodyn 187:139–143PubMedGoogle Scholar
  14. 14.
    Bajgar J, Patocka J, Fusek J, Herink J, Hrdina V (1974) Acta Nerv Super 16:253–255Google Scholar
  15. 15.
    Samson F, Pazdernik TL, Cross RS, Churchhill L, Giesler MP, Nelson SR (1985) Proc West Pharmacol Soc 28:183–185PubMedGoogle Scholar
  16. 16.
    Brown B, Haegerstrom-Portnoy G, Adams AJ, Jones RT, Jampolsky A (1982) Aviat Space Environ Med 53:759–765PubMedGoogle Scholar
  17. 17.
    Makusheva VP, Kitaev EM, Snetkova MG, Lupanova GE (1987) Ark Anat Gistrol Embriol 92:71–74Google Scholar
  18. 18.
    Sram RJ (1975) Acta Nerv Super 17:253–254Google Scholar

KC

  1. 1.
    Ciba AG, Schw Pat 183,065 (1936/1934), zit. nach CA (1936) 30:85316Google Scholar
  2. 2.
    Hill AJ, Holmes RB (American Cyanamid Co.), U S Pat 2,394,770 (1946/1942), zit. nach CA (1946) 40:31414Google Scholar
  3. 3.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, LondonGoogle Scholar
  4. 4.
    Jefferies JP, Phillips JI (1956) J Pharm Pharmacol 8: 907–913PubMedCrossRefGoogle Scholar

ME

  1. 1.
    Watthey JWH, Stanton JL, Desai M, Babiarz JE, Finn BM (1985) J Med Chem 28:1511PubMedCrossRefGoogle Scholar
  2. 2.
    Boyer SK, Pfund RA, Portmann RE, Sedelmeier GH, Wetter HF (1988) Helv Chim Acta 71:337–343CrossRefGoogle Scholar

MA

  1. 1.
    BoyerSK, Pfund RA, Portmann RE, Sedelmeier GH, Wetter HF (1988) Helv Chim Acta 71:337–343CrossRefGoogle Scholar

MA

  1. 1.
    Kaiser G, Ackermann R, Brechbühler S, Dieterle W (1989) Biopharm Drug Dispos 10:365–376PubMedCrossRefGoogle Scholar
  2. 2.
    Kaiser G (1990) Benazepril-pharmacokinetic profile in specific subpopulations. In: Bruner HR, Salvetti A, Sever PS (Hrsg.) benazepril: profile of a new ACE inhibitor, Royla Society of Medicine Services International Congress and Symposium Series No. 166, Royal Society of Medicine Service Ltd., London New York, S. 29–39Google Scholar
  3. 3.
    Waldmeier F, Kaiser G, Ackermann R, Faigle JW, Wagner J, Barner A, Lasseter KC (1991) Xenobiotica21 im DruckGoogle Scholar
  4. 4.
    Dieterle W, Ackermann R, Kaiser G (1989) Eur J Clin Pharmacol36 (Suppl.):A303Google Scholar
  5. 5.
    Chen B, Perich R, Jackson B, Paxton D, Pupic V, Fabris B, Johnson Cl (1990) Inhibition of tissun ACE by benazepril. In: Brunner HR, Salvetti A, Sever PS (Hrsg.) Benazepril: profile of a new ACE inhibitor. Royal Society of Medicine Services International Congress and Symposium Series no. 166, Royal of Medicine Services Ltd., London New York, S. 17–27Google Scholar
  6. 6.
    Kaiser G, Ackermann R, Dieterle W, Durnin CJ, McEwen J, Ghose K, Richens A, Holmes IB (1990) Eur J Clin Pharmacol 138:379CrossRefGoogle Scholar
  7. 7.
    Kaiser G, Ackermann R, Gschwind HP, James IM, Sprengers D, Mclntyre N, De Falco A, Holmes IB (1990) Biopharm Drug Dispos 11:753–764PubMedCrossRefGoogle Scholar
  8. 8.
    Webb RL, Miller D, Traina V, Gomez HJ (1990) Cardiovasc Drug Rev 8:89–104CrossRefGoogle Scholar
  9. 9.
    Van Hecken A, De Lepeleire I, Verbesselt R, Arnout J, Angehrn J, Youngberg C, De Schepper PJ (1988) Int J Clin Pharm Res VIII:315–319Google Scholar
  10. 10.
    Balfour JA, Goa KL (1991) Drugs 42:511–539PubMedCrossRefGoogle Scholar

Mj/Ki/sl

  1. 1.
    Lotti B (1975) Bull Chim Farm 114:663–667Google Scholar
  2. 2.
    Cavazutti G, Gagliardi L, Amato A, Profili M, Zagarese V, Tonelli D, Gattavecchia E (1983) J Chomatogr 268:528–534CrossRefGoogle Scholar
  3. 3.
    Farago E , Simon J (1970) Arzneim Forsch 20: 1378–1380Google Scholar
  4. 4.
    Daldrup T, Susanto F, Michalke P (1981) Fresenius Z Anal Chem 308:413–427CrossRefGoogle Scholar
  5. 5.
    Bock PR (1976) Int J Clin Pharmacol 13:246–252Google Scholar
  6. 6.
    Posgay-Kovacs E, Fischer A (1975) Pharmazie 30:1609Google Scholar
  7. 7.
    Simonyi I, Kekesy I, Toth Z (1967) Pharmazie 22:23–25Google Scholar
  8. 8.
    Auer L, Trummer G (1980) Eur Neurol 19:61–66PubMedCrossRefGoogle Scholar
  9. 9.
    Egawa M, Nahjima I, Misu Y (1982) Jap J Pharmacol 32:273–281PubMedCrossRefGoogle Scholar
  10. 10.
    Gartner E, Enzenross HG, Vlahov V, Schanzenbacher P, Brandt H, Betz E (1975) Arzneim Forsch 25:887–891Google Scholar
  11. 11.
    Vetterlein F, Halfter R, Schmidt G (1979) Arzneim Forsch 29:747–751Google Scholar
  12. 12.
    Kukovetz WR, Poch G, Holzmann S, Paietta E (1975) Arzneim Forsch 25:722–726Google Scholar
  13. 13.
    Brandt H, Schanzenbacher P, Enzenross HG, Betz E (1975) Arzneim Forsch 25:1.393–1.396Google Scholar
  14. 14.
    Kohler E, Motzer S, Greff K (1975) Res Exp Med Berl 165:111–125PubMedCrossRefGoogle Scholar
  15. 15.
    Nanasi PP, Bodnar Z, Danko M (1989) Gen Physiol Biophys 8:447–458PubMedGoogle Scholar
  16. 16.
    Nanasi PP, Varro A, Rablocky G, Danko M (1987) Arch Int Pharmacodyn Ther 290:278–287PubMedGoogle Scholar
  17. 10.
    Ernst E (1983) Muench Med Wochenschr 125:90–92Google Scholar
  18. 11.
    Bamberg E, Bauer O, Herrmann W, Kroemer H, Lippmann M, Müller X, Segmann H, Breddin K (1978) Blut 37:327–339PubMedCrossRefGoogle Scholar
  19. 12.
    Bayer R, Plewa S, Borcescu E, Claus W (1988) Arzneim Forsch 38:1.765–1.767Google Scholar
  20. 13.
    Bielenberg GW, Hayn C, Krieglstein J (1986) Biochem Pharmacol 35:2.693–2.702CrossRefGoogle Scholar
  21. 14.
    Hockwin O (1977) Fortsch Med 95:1.837–1.840Google Scholar
  22. 15.
    Heidrich H, Schirop T, Fichte K (1977) Med Klin 72:94–101PubMedGoogle Scholar
  23. 16.
    Bock PR (1976) Int J Clin Phamacol Biopharm 13:246–252Google Scholar
  24. 17.
    Eckard R, Weyenmeyer R (1985) Arzneim Forsch 35:1.587–1.590Google Scholar
  25. 18.
    Kimura K, Nagata A, Miyawaki H (1979) Xenobiotica 9:119–127PubMedCrossRefGoogle Scholar
  26. 19.
    Trubestein G, Trubestein R, Ludwig M (1989) Fortschr Med 107:781–784PubMedGoogle Scholar
  27. 20.
    Garweg G, Herrmann WM, Kern U (1987) Z Gerontol 20:56–62PubMedGoogle Scholar
  28. 21.
    Mangabeira Albernaz PL (1988) Acta Otolaryngol Suppl Stockh 460:99–103CrossRefGoogle Scholar
  29. 22.
    Rieger H, Klose HJ, Schmid Schonbein H, Wurzinger L (1978) Thromb Res 12:353–356PubMedCrossRefGoogle Scholar
  30. 23.
    Fazekas T, Lajko K, Kiss Z, Somogyi I (1981) Orv Hetü 122:3.139–3.142Google Scholar
  31. 24.
    Nagy L (1970) Arzneim Forsch 10a:1.391–1.402Google Scholar
  32. 25.
    Komlos E, Petöcs LE (1970) Arzneim Forsch 10a:1.338–1.357Google Scholar

KC

  1. 1.
    Pallos L, Budai Z, Zolyomi G (1972) Arzneim Forsch 22:1502–1505Google Scholar
  2. 1.
    Ozegowski W, Krebs D (1963) J prakt Chem 20:178–186CrossRefGoogle Scholar

AE

  1. 1.
    Hesse P, Jaschke E, Anger G (1972) Dtsch Gesundh Wesen 27:2058–2064Google Scholar
  2. 2.
    Preiss R, Sohr R, Matthias M et al. (1985) Pharmazie 40:782–784PubMedGoogle Scholar
  3. 3.
    Anger G, Fink R, Fleischer J et al. (1975) Dt Gesundh Wesen 30:1.280–1.285Google Scholar
  4. 4.
    Brockmann B, Kirchhof I, Geschke E et al. (1989) Arch Geschwulstforsch 59:341–346PubMedGoogle Scholar

OJ

  1. 1.
    Rabinger DJ, Joullie MM (1964), J Org Chem 29(l):476–482CrossRefGoogle Scholar
  2. 2.
    Raban M et al. (1985) J Org Chem 50:2205–2210CrossRefGoogle Scholar
  3. 3.
    Feitelson BN. Rothstein R (1958) J Chem Soc 2426–2428Google Scholar

QO

  1. 1.
    RabanM et al (1985) J Org Chem 50:2205–2210CrossRefGoogle Scholar

QO

  1. 1.
    Topliss JG et al (1961) J Org Chem 26:3842CrossRefGoogle Scholar
  2. 2.
    Klosa J, Voigt H (1962) J Pract Chem 16:264CrossRefGoogle Scholar
  3. 3.
    Ågren A, Bäck T, (1973) Acta Pharm suec 10:223PubMedGoogle Scholar
  4. 4.
    Hennig UGG, Chatten LG, Moskalyk RE, Ediss C,(1981) Analyst 106:557CrossRefGoogle Scholar
  5. 5.
    Florey K, Russo-Alesi FM (1976) in Anal 5:1Google Scholar
  6. 6.
    Fathalla B (1988) Analyst 113:637CrossRefGoogle Scholar
  7. 7.
    Van Kerchove C, Bontemps R, Schoenmakers A (1982) J Pharm Pharmacol 34:420PubMedCrossRefGoogle Scholar
  8. 8.
    Fagerlund C, Hartvig P, Lindstrom B (1979) J Chromatogr 168:107PubMedCrossRefGoogle Scholar

UG

  1. 1.
  2. 2.
    Greenberg G (1985) Brit Med J 291:97–104CrossRefGoogle Scholar
  3. 3.
    Ray WA, Griffin MR, Downey W, Melton III LJ (1989) Lancet 687–689Google Scholar
  4. 4.
    Waller P, Ramsay LE (1989) J Human Hypertension 3:457–461Google Scholar
  5. 5.
    Bendroflumethiazid (1986) BAz 177a:4–5Google Scholar

Oß/Al

  1. 1.
    Ito A, Hamanaka W, Takagi H, Wada T, Kawada K (Sankyo Co., Ltd.), DBP 1,130,811 (1962/1959), zit. nach CA (1962) 57:13764gGoogle Scholar
  2. 2.
    Ito A, Hamanaka W, Okamoto K, Tamura C, Takamine Kenkyusho Nempo (1962) 14:64–66, zit. nach CA (1963) 59:3920aGoogle Scholar
  3. 3.
    Kotera K, Chem Pharm Bull (1965) 13:440–443, zit. nach CA (1965) 63:5495eGoogle Scholar

ME

  1. 1.
    Index Nominum (1982)Google Scholar
  2. 2.
    Bäßler KH, Grühn E, Loew D, Pietrzik K (1992) Vitamin-Lexikon, Fischer, StuttgartGoogle Scholar
  3. 3.
    Monographie Allithiamine/Lipoidlösuche Thiamin-Derivate, Bundesanzeiger (im Druck)Google Scholar

KP

  1. 1.
    Trucant A, PatayM, Allain P (1979) J Chromatogr 164:195–203Google Scholar

QO

  1. 1.
    Liebster J, Andrysek O (1959) Nature 184:913PubMedCrossRefGoogle Scholar

Et

  1. 1.
    Rhiessen JJ (1982) Pharmacokinetics of salicylates. In: Barnett HJM, Hirsh J, Mustard JF (Hrsg.) Acetylsalicylic acid. New uses for an old drug, Raven Press, New York, S. 49–61Google Scholar
  2. 2.
    Robertson A, Glynn JB, Watson AK (1972) Xenobiotika 2:339–347CrossRefGoogle Scholar
  3. 3.
    ChayenJ,Bitensky L, Ubbi GS (1972) Beitr Path Anat 147:6–11CrossRefGoogle Scholar
  4. 4.
    Rainsford KD (1984) Butterworths, London BostonGoogle Scholar
  5. 5.
    Hart G, Nicholson PA (1971) Clin Trial J 8:51–56Google Scholar
  6. 6.
    May L, Swoboda W (1974) J Rheumatol 33:353–360Google Scholar
  7. 7.
    Lee P, Anderson JA, Miller J, Webb J, Buchanan WW (1976) J Rheumatol 3:283–293PubMedGoogle Scholar
  8. 8.
    Miehle W (1985) Thieme-Verlag, Stuttgart, S. 63–65Google Scholar
  9. 9.
    Engelhardt G (1984) Arzneim Forsch 34:992–998Google Scholar
  10. 10.
    Bromm B, Rundshagen D, Scharein E (1989) Pharmazeut Ztg 134:1.256–1.262Google Scholar
  11. 11.
    Kölle G (1971) Z Rheumaforschg 30:227–230Google Scholar
  12. 12.
    Hamill JJ (1977) J Internat Med Res 5:265–269Google Scholar
  13. 13.
    Manz G, Glynn JP (1985) zit. in Miehle (Ref. 8)Google Scholar
  14. 14.
    Aylward M, Maddock J, Ress P, Thomas GM, Wheeldon R, Holly F (1976) Scand J Rheumatol 13(Suppl):9–15CrossRefGoogle Scholar
  15. 15.
    Franke M, Manz G, Glynn JP (1976) Scand J Rheumatol 13(Suppl):13–18CrossRefGoogle Scholar
  16. 16.
    Mar 29, Benorilate. S. 246–247Google Scholar
  17. 17.
    Prasad R (1980) Practitioner 224:325PubMedGoogle Scholar
  18. 18.
    Croft DN, Cuddigan JHP, Sweetland C (1972) Brit Med J 3:545–547PubMedCrossRefGoogle Scholar
  19. 19.
    Danhof IE, Kaliley JD, Guinn EC (1972) Curr Ther Res 14:583–585PubMedGoogle Scholar
  20. 20.
    Marshall AJ, Sheridan P (1973) Brit Med J 1:175–178PubMedCrossRefGoogle Scholar

EH

  1. 1.
    Cashin CH, Dawson W, Kitchen EA (1977) J Pharm Pharmacol 29:330–336PubMedCrossRefGoogle Scholar
  2. 2.
    Miyazawa K, Iimori Y, Makino M, Mikami T, Miyasaka K (1985) Jpn J Pharmacol 38:199–205PubMedCrossRefGoogle Scholar
  3. 3.
    Sircar JC, Schwender CF, Johnson EA (1983) Prostaglandins 25:393–396PubMedGoogle Scholar
  4. 4.
    Baumann I, Baumann J, Wurm G (1984) BrJ Pharmacol 83:959–964PubMedCrossRefGoogle Scholar
  5. 5.
    Naude SP, Anderson R, Eftychis E, Theron A, van Wyk H, Joone GK (1983) S Afr Med J 63:926–930PubMedGoogle Scholar
  6. 6.
    Anderson R, Lukey PT, Naude SP, Joone G (1984) Agents Actions 14:238–246PubMedCrossRefGoogle Scholar
  7. 7.
    Palmoski MJ, Brandt KD (1983) Arthritis Rheum 26:771–774PubMedCrossRefGoogle Scholar
  8. 8.
    Smith GL, Goulbourn RA, Burt RA, Chatfield DH (1977) Br J Clin Pharmacol 4:585–590PubMedCrossRefGoogle Scholar
  9. 9.
    Albengres E, Urien S, Kusmierek J, Tillement JP (1982) Eur J Rheumatol Inflamm 5:87–97PubMedGoogle Scholar
  10. 10.
    Brogard JM, Audhuy B, Spach MO (1981) Schweiz Med Wochenschr 111:197–201PubMedGoogle Scholar
  11. 11.
    Schönhöfer PS (1983) Pharmazeut Ztg 128:735–739Google Scholar
  12. 12.
    Dahl SL, Ward Jr. (1982) Pharmacotherapy 2:354–366PubMedGoogle Scholar
  13. 13.
    Halsey JP, Cardoe N (1982) Br Med J Clin Res 284:1.365–1.368Google Scholar
  14. 14.
    Rainsford KD (1982) Eur J Rheumatol Inflamm 5:148–164PubMedGoogle Scholar
  15. 15.
    Furet Y, Metman EH, Breteau M, Bertrand J (1987) Ann Gastroenterol Hepatol Paris 23:367–374PubMedGoogle Scholar
  16. 16.
    Prescott LF (1986) Med Toxicol l(Suppl. l):44–56Google Scholar
  17. 17.
    Bigby M, Stern R (1985) J Am Acad Dermatol 12:866–876PubMedCrossRefGoogle Scholar
  18. 18.
    Artuso T, Bernadou J, Meunier B, Paillous N (1990) Biochem Pharmacol 39:407–413PubMedCrossRefGoogle Scholar
  19. 19.
    Wiskemann A (1981) Arzneim Forsch 31:730–732Google Scholar
  20. 20.
    Feldman C, Lampert I, Parke A (1982) Rheumatol Rehabil 21:222–224PubMedCrossRefGoogle Scholar
  21. 21.
    Braun-Falco O, Balda BR, Korting HC, Blick U, Loeschke K, Begemann F (1982) Muench Med Wochenschr 124:757–759Google Scholar

Hs/KA

  1. 1.
    Gassim AEH et al (1986) Int J Pharm 34:23–28CrossRefGoogle Scholar
  2. 2.
    Kuhnert-Brandstätter M et al (1974) Sci. Pharm 42:241–242Google Scholar
  3. 3.

sT

  1. 1.
    Janssen PAJ, van Bever WFM (180) Butyrophenones and Diphenylbutylpiperdines. In: Hoffmeister F, Stille G (Hrsg.) Psychotropic drugs. Parti: Antipsychotics and antidepressants. Handb exp. Pharm 55/I, Springer-Verlag, Berlin Heidelberg New York, S. 27–42Google Scholar
  2. 2.
    Haase HJ (1985) Clinical observations on the action of neuroleptics. In: Haase HJ, Janssen PAJ (Hrsg.) The action of neuroleptic drugs, Elsevier, Amsterdam New York Oxford, S. 1–284Google Scholar
  3. 3.
    Nedopil N, Eben E, Klein H, Krüger R, Rüther E, Schmauss M (1985) Pharmacopsychiat 18:63–66CrossRefGoogle Scholar
  4. 4.
    Schwarz H (1966) Med Welt 17:2.642–2.643Google Scholar
  5. 5.
    Janssen PAJ (1985) The pharmacology of neuroleptic drugs. In: Haase HJ, Janssen PAJ (Hrsg.) The action of neuroleptic durgs, Elsevier, Amsterdam New York Oxford, S. 285–318Google Scholar
  6. 6.
    Furlanut M, Perosa A, Benetello P, Colombo G (1984) Therapeutic drug monitoring 9:343–346CrossRefGoogle Scholar
  7. 7.
    Schöllnhammer G, Spechtmeyer H, Hesse C, Husser J, Ebeling H, Parish HM (1985) Pharmacopsychiat 18:54–55CrossRefGoogle Scholar
  8. 8.
    Krüger R, Mengel I, Kuss HJ (1984) J Chromatogr 311:109–116PubMedGoogle Scholar
  9. 9.
    Kuemmerle HP (1989) Klinisch-Pharmakologische Arzneimittelprofile. Benperidol, ecomedGoogle Scholar

OT

  1. 1.
    Janssen PAJ, van Bever WFM (180) Butyrophenones and Diphenylbutylpiperdines. In: Hoffmeister F, Stille G (Hrsg.) Psychotropic drugs. Parti: Antipsychotics and antidepressants. Handb exp. Pharm 55/I, Springer-Verlag, Berlin Heidelberg New York, S. 27–42Google Scholar
  2. 2.
    Haase HJ (1985) Clinical observations on the action of neuroleptics. In: Haase HJ, Janssen PAJ (Hrsg.) The action of neuroleptic drugs, Elsevier, Amsterdam New York Oxford, S. 1–284Google Scholar
  3. 3.
    Nedopil N, Eben E, Klein H, Krüger R, Rüther E, Schmauss M (1985) Pharmacopsychiat 18:63–66CrossRefGoogle Scholar
  4. 4.
    Schwarz H (1966) Med Welt 17:2.642–2.643Google Scholar
  5. 5.
    Janssen PAJ (1985) The pharmacology of neuroleptic drugs. In: Haase HJ, Janssen PAJ (Hrsg.) The action of neuroleptic durgs, Elsevier, Amsterdam New York Oxford, S. 285–318Google Scholar
  6. 6.
    Furlanut M, Perosa A, Benetello P, Colombo G (1984) Therapeutic drug monitoring 9:343–346CrossRefGoogle Scholar
  7. 7.
    Schöllnhammer G, Spechtmeyer H, Hesse C, Husser J, Ebeling H, Parish HM (1985) Pharmacopsychiat 18:54–55CrossRefGoogle Scholar
  8. 8.
    Krüger R, Mengel I, Kuss HJ (1984) J Chromatogr 311:109–116PubMedGoogle Scholar
  9. 1.
    Aktieselskabet Pharmacia, Brit Pat 914,008 (1962,1960), zit. nach CA (1963) 58:12523aGoogle Scholar
  10. 2.
    Mortensen HTh (Aktieselskabet Pharmacia) Dan Pat 96, 113 (1963, 1960), zit. nach CA (1966) 64:12649aGoogle Scholar

ME

  1. 1.
    Kurz H (1989) Antitussiva und Expektoranzien, Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  2. 2.
    Kochen MM (1989) pharmakritik 11:1–4Google Scholar

SZ

  1. 1.
    Aktieselskabet Pharmacia, Brit. Pat. 914, 008 (1962, 1960), zit. nach CA (1963) 58:12523aGoogle Scholar
  2. 2.
    Mortensen HT (Aktieselskabet Pharmacia) Dan. Pat. 96, 113 (1963, 1960), zit. nach CA (1966) 64:12649aGoogle Scholar

ME

  1. 1.
    F. Hoffmann-LaRoche & Co. AG, Belg Pat 619,015 (1962, 1961), zit nach CA (1963) 59:6520cGoogle Scholar

ME

  1. 1.
    Cedarbaum JM, Schleifer LS (1990) Drugs for Parkinson’s disease, spasticity, and acute muscle spasms. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gillman’s the pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York, S. 463–484Google Scholar
  2. 2.
    Mar 29, S. 1010Google Scholar
  3. 3.
    Birkmayer W (1969) Wien Klin Wschr 81:677–679PubMedGoogle Scholar
  4. 4.
    Kent AP, Stern GM, Webster RA (1990) Br J Pharmacol 100:743–748PubMedCrossRefGoogle Scholar
  5. 5.
    Männistro PT, Kaakkola S (1990) Pharmacol Toxicol 66:317–323CrossRefGoogle Scholar
  6. 6.
    Quinn NP (1984) Drugs 28:236–262PubMedCrossRefGoogle Scholar
  7. 7.
    Koller WC, Hubble JP (1990) Neurology 40(Suppl.3):40–47PubMedGoogle Scholar
  8. 8.
    Cedarbaum JM (1987) Clin Pharmacokinet 13:141–178PubMedCrossRefGoogle Scholar
  9. 9.
    Johansen PA, Wolf WA, Kuhn DM (1991) Biochem Pharmacol 41:625–628PubMedCrossRefGoogle Scholar
  10. 10.
    Levodopa und Benserazid. BAz Nr. 76 vom 21.04.1989Google Scholar
  11. 11.
    Müller EE, Locatelli V, Cella S, Penalva A, Novelli A, Cocchi D (1983) Drugs 25:399–132PubMedCrossRefGoogle Scholar

NB

  1. 1.
    Matsukawa T, Kawasaki H (1953) Yakugaku Zasshi 73:705–708, zit. nach CA (1954) 48:7017aGoogle Scholar
  2. 2.
    Yoshida S (1954) Yakugaku Zasshi 74:993–997, zit. nach CA (1955) 49:11.664eGoogle Scholar
  3. 3.
    Yoshida S, Kataoka M (1958) Chem Pharm Bull 6:576–577, zit. nach CA (1959) 53:12.292cCrossRefGoogle Scholar

ME

  1. 1.
    Index Nominum (1982)Google Scholar
  2. 2.
    Bäßler KH, Grühn E, Loew D, Pietrzik K (1992) Vitamin-Lexikon, Fischer, StuttgartGoogle Scholar

KP

  1. 1.
    Niederau C, Grendell JH (1985) Gastroenterology 88:1.973–1.995Google Scholar
  2. 2.
    Meyer B, Gyr K (1987) Leber Magen Darm 17:334–338PubMedGoogle Scholar
  3. 3.
    Scharpé S, Illano L (1987) Clin Chem 33:5–12PubMedGoogle Scholar
  4. 4.
    Mar 29, S. 938Google Scholar
  5. 5.
    Laufer D, Cleghorn G, Forstner G, Ellis L, Koren G, Durie P (1991) Gastroenterology 101:207–213PubMedGoogle Scholar
  6. 6.
    Gardner MLG, Mitchell CJ (1981) Q J Exp Physiol 66: 17–24PubMedGoogle Scholar
  7. 7.
    Sprakties G (1986) Naunyn-Schmiedeberg’s Arch Pharmacol 332:R38Google Scholar
  8. 8.
    Weizman Z, Forstner GG, Gaskin KJ, Kopelman H, Wong S, Durie PR (1985) Gastroenterology 89:596–604PubMedGoogle Scholar
  9. 9.
    Toskes PP (1983) Gastroenterology 85:565–569PubMedGoogle Scholar

PK

  1. 1.
    Handbook of Pharmaceutical Excepients, APhA Washington, US A, S 9Google Scholar
  2. 2.
    Lagaly G., Fahn R. (1983): Ullmanns Enzyklopädie der technischen Chemie, Bd. 23, 4 Aufl.: 311–326Google Scholar

BK

  1. 1.
    Sykes G (1965) Disinfection & Sterilization, Spon, London, S. 362–376Google Scholar
  2. 2.
    Weuffen W, Kramer A, Adrian V (1986) Vergleichende Wertung über Nutzen und Risiko bei der chemischen Desinfektion. In: Knoll KH (Hrsg.) Angewandte Krankenhaushygiene bei Krankenhausbau, Medizintechnik und Krankenhausbetrieb. Bd. 2, Med Zentrum Hygiene u Med Mikrobiol der Philipps-Univ Marburg, S. 333–350Google Scholar
  3. 3.
    Moldenhauer D (1984) Zbl Bakt Hyg I Abt Orig B 179:544–554Google Scholar
  4. 4.
    Thraenhart O, Dermietzel R, Kuwert E, Scheiermann N (1977) Zbl Bakt Hyg I Abt Orig B 164:1–21Google Scholar
  5. 5.
    Richards RME, Mizrahi Lynette M (1978) J Pharm Sci 67:380–383PubMedCrossRefGoogle Scholar
  6. 6.
    NN (1989) J Am Coll Toxicol 8:589–625CrossRefGoogle Scholar
  7. 7.
    Band emir B, Pambor M (1985) Toxische (irritative) Nebenwirkungen von Antiseptika an der Haut. In: Kramer A, Berencsi G, Weuffen W (Hrsg.) Toxische und allergische Nebenwirkungen von Antiseptika. Handbuch der Antiseptik, Bd. I/5, Volk und Gesundheit, Berlin, S. 37–66Google Scholar
  8. 8.
    Reybrouck G (1987) Antiseptic Drugs and Disinfectants. In: Dukes MNG (Hrsg.) Side Effect of Drugs, Annual 11.Elseviers Science Publishers B.V., S.219–222Google Scholar
  9. 9.
    Bolton L, Oleniacz W, Constantine B, Kelliher BO, Jensen D, Means B, Rovee D (1985) Repair and Antibacterial Effects of Topical Antiseptic Agents in Vivo. In: Maibach HI, Lowe NJ (Hrsg.) ;Models in Dermatology, Vol. 2, Karger Verlag, Basel, S. 145–158Google Scholar
  10. 10.
    Krasilnikow AP, Adartschenko AA (1987) Resistenzentwicklung von Staph aureus, Pseud. aeruginosa und Enterobacteriaceae gegen Antiseptika. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Antibakterielle, antifungielle und antivirale Antiseptik-ausgewählte Wirkstoffe. Handbuch der Antiseptik, Bd.II/3, Volk und Gesundheit, Berlin, S. 123–139Google Scholar
  11. 11.
    Ciancio SG, Mather ML, Bunnel HL (1975) J Periodontol 46:397–401PubMedCrossRefGoogle Scholar
  12. 12.
    Kramer A, Zbinden G, Stephan U, Koch St, Koch D, Junghans A (1985) Akute Toxizität von Antiseptika. In: Kramer A, Berencsi G, Weuffen W (Hrsg.) Toxische und allergische Nebenwirkungen von Antiseptika. Handbuch der Antiseptik, Bd. I/5, Volk und Gesundheit, Berlin, S. 113–132Google Scholar
  13. 13.
    Wolff F (1961) Arch Toxikol 19:8–14PubMedCrossRefGoogle Scholar
  14. 14.
    Ludewig R, Lohs K (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 49–50Google Scholar

ak

  1. 1.
    a) Labaz, DBP 1.076.702 (20.12.1957); b) Labaz, USP 3.012.042 (5.12.1961)Google Scholar
  2. 2.
    Persönliche Mitteilung, Lindopharm GmbH, HildenGoogle Scholar
  3. 3.
    Bonn R, Grote H, Sandrock K (1987) Xenobiotica 17:881–886PubMedCrossRefGoogle Scholar

Sf

  1. 1.
    Deltour G, Binon , Charlier R (1963) Arch Int Pharmacodyn Ther 145:356–377PubMedGoogle Scholar
  2. 2.
    Deltour G, Charlier , Binon F (1965) Arch Int. Pharmacodyn Ther 154:94–107PubMedGoogle Scholar
  3. 3.
    Betz E, Eitel W (1978) Arzneim Forsch 28:626–630Google Scholar
  4. 4.
    Zwillenberg LO, Zwillenberg HHL, Bösiger G (1982) Arzneim Forsch 32:1.114–1.120Google Scholar
  5. 5.
    Knehr HE, Betz E (1983) Arzneim Forsch 33:211–214Google Scholar
  6. 6.
    Roth J, Betz E, Schlote W (1980) Arzneim Forsch 30:1897–1902Google Scholar
  7. 7.
    Schmidt A, Staubesand J, Buddecke E (1982) Arzneim Forsch 32:810–815Google Scholar
  8. 8.
    Filipovic I, Buddecke E (1979) Arzneim Forsch 29:1578–1580Google Scholar
  9. 9.
    Lücker RW, Wetzelsberger K (1979) Arzneim Forsch 29:842–846Google Scholar
  10. 10.
    Wood SG, John BA, Chasseaud LF, Bonn R, Grote H, Sandrock K, Darragh A, Lambe RF (1987) Xenobiotica 17:881–896PubMedCrossRefGoogle Scholar
  11. 11.
    Bekaert J, Rozenblum CH, Deltour G (1965) Arch Int Pharmacodyn Ther 158:165–172PubMedGoogle Scholar
  12. 12.
    Mörl H, Diehm C, Zimmermann R, Schöffel G, Alter E (1980) Münch Med Wschr 122:277–280Google Scholar
  13. 13.
    Pevny I (1984) Contact dermatitis 11:122–124PubMedCrossRefGoogle Scholar
  14. 14.
    Barany G, Larrey D, Pessayre D, Gott C, Rueff B,Benhamou JP (1987) J Hepatol 5:332–335CrossRefGoogle Scholar

GA

  1. 1.
    Phillips RF (Merck & Co., Inc.) U S Pat 2,595,405 (1952), zit. nach CA (1953) 47:2218hGoogle Scholar
  2. 2.
    Weijlard J (Merck & Co., Inc.), U S Pat 2,706,198 (1955), zit. nach CA (1956) 50:2688hGoogle Scholar

ME

  1. 1.
    Syvalahti EKG, Kunelius R, Lauren L (1988) Pharmacol Toxicol 62:90–94PubMedCrossRefGoogle Scholar
  2. 2.
    Antidyskinetics, In: Drug Information for the health care professional (USPDI) (1990) Volume I A, S.392–398, The United States Pharmacopeial Convention, Rockville, Maryland (USA)Google Scholar
  3. 3.
    Smith JM (1980) J Clin Psychiatry 41:351–354PubMedGoogle Scholar
  4. 4.
    Tune LE,McHugh PR, Coyle JT (1981) Ann Emerg Med 10:98–100Google Scholar
  5. 1.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs. Pharmaceutical Press, LondonGoogle Scholar
  6. 2.
    Phillips RF (Merck & Co., Inc.), US Pat. 2,595,405 (1952), zit. nach CA (1953) 47:2218hGoogle Scholar

ME

  1. 1.
    Dibbern HW, UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor AulendorfGoogle Scholar

SH

  1. 1.
    Zöllner N,Griebsch A, Fink JK (1970) Dtschmed Wochenschr 95:2.405–2.412Google Scholar
  2. 2.
    Diamond HS (1978) Uricosuric Drugs. In: Kelly WN, Weiner IM (Hrsg.) Uric Acid, Handb Exp Pharmacol 51:459–484CrossRefGoogle Scholar
  3. 3.
    Jain AK, Ryan Jr., McMahan FG, Noveck RJ (1974) Arthr and Rheum 17:149–157CrossRefGoogle Scholar
  4. 4.
    Heel RC, Brogden RN, Speight TM, Avery GS (1977) Drugs 14:349–366PubMedCrossRefGoogle Scholar
  5. 5.
    Sinclair DS, Fox IH (1975) J Rheumatol 19:183–190Google Scholar
  6. 6.
    Kramp RA, Lenoir R (1975) Am J Physiol 228:875–883PubMedGoogle Scholar
  7. 7.
    Levinson DJ, Decker DE, Sorensen LB (1982) Ann clin Lab Sci 12:73–77PubMedGoogle Scholar
  8. 8.
    Sorensen LB, Levinson DJ (1976) Arthr and Rheum 19:183–190CrossRefGoogle Scholar
  9. 9.
    Rodilla F, Sanchez-Beltran MJ, Izquierdo R, Gomez-Ruiz MD, Cabo J (1988) Biochem Pharmacol 37:3.561–3.563CrossRefGoogle Scholar
  10. 10.
    Becker H, Mack T, Gerok W (1978) Klin Wochenschr 56:835–837CrossRefGoogle Scholar
  11. 11.
    Kramar R, Müller MM (1973) Experientia 29:391–392PubMedCrossRefGoogle Scholar
  12. 12.
    Walter-Sack J, de Vries JX, Ittensohn A, Kohlmeier M, Weber E (1988) Klin Wochenschr 66:160–166PubMedCrossRefGoogle Scholar
  13. 13.
    Broekhuysen MP, Sion R, Demeulenaere L, van Hee M (1972) Europ J clin Pharmacol 4:125–130CrossRefGoogle Scholar
  14. 14.
    Yü TF (1976) J Rheumatol 3:305–312PubMedGoogle Scholar
  15. 15.
    Delbarre F, Auscher C, Oliver J, Rose A (1967) Sem Hop Paris 43:1.127–1.133Google Scholar
  16. 16.
    Ferber H, Vergin H, Hitzenberger G (1981) Eur J Clin Pharmacol 19:431–435PubMedCrossRefGoogle Scholar
  17. 17.
    de Vries JX, Walter-Sack J, van de Loo A, Kocher J (1986) J Chromatography 382:167–174Google Scholar
  18. 18.
    de Vries JX, Walter-Sack I, Ittensohn A (1987) J Chromatography 417:420–427Google Scholar
  19. 19.
    Dinnendahl V, Fricke U (1982) Benzbromaron, Arzneistoffprofile, Bd. 1–5, Govi-Verlag, FrankfurtGoogle Scholar
  20. 20.
    Yamamoto T, Moriwaki Y, Takahashi S, Hada T, Higashino K (1988) Nephron 48:116–120PubMedCrossRefGoogle Scholar
  21. 21.
    Ruffer C, Zorn G, Henkel E, Mitzkat HJ (1982) Arzneim Forsch 32:1.149–1.152Google Scholar
  22. 22.
    Löffler W, Gröbner W, Zöllner N (1983) Arzneim Forsch 33:1.687–1.691Google Scholar
  23. 23.
    Colin JN, Farinotti R, Fredj G, Tod M, Clavel JP, Vignon E, Dietlin F (1986) Eur J Clin Pharmacol 31:53–58PubMedCrossRefGoogle Scholar
  24. 24.
    Gröbner W, Zöllner N (1989 Klin Wochenschr 67:313–315PubMedCrossRefGoogle Scholar

  1. 1.
  2. 2.
    USP 2115250 (Rohm & Haas; ert. 1938; Anm. 1936)Google Scholar
  3. 3.
    USP 2170111 (Rohm & Haas; ert. 1939; Anm. 1936)Google Scholar
  4. 4.
    USP 2229024 (Rohm & Haas; ert. 1941; Anm. 1939)Google Scholar

Rj

  1. 1.
    Wallhäußer KH (1988) Praxis der Sterilisation, Desinfektion, Konservierung, 4. Aufl., Thieme Verlag, Stuttgart New York, S. 553–554Google Scholar
  2. 2.
    Nater JP, De Groot AC (1983) Excerpta Medica, AmsterdamGoogle Scholar
  3. 3.
    NN (1985) J Am Coll Toxicol 4:65Google Scholar
  4. 4.
    Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 49–50Google Scholar

ak

  1. 1.
    Upjohn Co (1957) Heinzelmann V, Aspergren BD USP 2.789.138; CA (1957) 51:12.972cGoogle Scholar
  2. 2.
    Moffat AC, JacksonJV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, LondonGoogle Scholar
  3. 3.
    Franceschini A, Duthel JM, Vallon JJ (1991) J Chromatogr 541:109–120PubMedCrossRefGoogle Scholar

NE

  1. 1.
    Upjohn Co (195s7) Heinzelmann V, Aspergren BD USP 2.789.138; CA (1957) 51:12.972cGoogle Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, LondonGoogle Scholar
  3. 3.
    Franceschini A, Duthel JM, Vallon JJ (1991) J Chromatogr541(l,2):109–120PubMedGoogle Scholar

NE

  1. 1.
    Upjohn Co (1957) Heinzelmann V, Aspergren BD USP 2.789.138; CA (1957) 51:12.972cGoogle Scholar

NE

  1. 1.
    Upjohn Co (1957) Heinzelmann V, Aspergren BD USP 2.789.138; CA (1957) 51:12.972cGoogle Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, LondonGoogle Scholar

NE

  1. 1.
    Ryan CW, Ainsworth C (1962) J Org Chem 27:2901–2905CrossRefGoogle Scholar
  2. 2.
    Kuhnert-Brandstätter M, Bösch L, Eckstein G (1978) Sci Pharm 46:180–188Google Scholar
  3. 3.
    Kiger JL, Kiger JG (1967) Ann Pharm Fr 25:601–612PubMedGoogle Scholar
  4. 4.
    Attwood DC (1076) J Pharm Pharmacol 28:407–409CrossRefGoogle Scholar
  5. 5.
    Lippold BC, Schneider G (1974) Arch Pharm 307:63–73CrossRefGoogle Scholar
  6. 6.
    Crommen J (1980) J Chromatogr 193:225–234CrossRefGoogle Scholar
  7. 7.
    Zyzynski W (1978) Acta Pol Pharm 35:321–327, zit. nach CA (1979) 90:61322mPubMedGoogle Scholar
  8. 8.
    Abdelkader MA, Taha AM, Abdelfattah S (1980) Pharmazie 35:30–32Google Scholar
  9. 9.
    Taha AM, Abdelkader MA, Abdelfattah S (1980) Pharmazie 35:93–95Google Scholar

gs

  1. 1.
    Fernex M (1980) Fortschritte auf dem Gebiet der von Trypanosomen hervorgerufenen Krankheiten. In: Gsell O (Hrsg.) Importierte Infektionskrankheiten, Epidemologie und Therapie, 5.Symp. Dt. Ges. Fortschr. Innere Med., Georg Thieme Verlag, Stuttgart New York, S. 130–134Google Scholar
  2. 2.
    Grunberg E, Beskid G, Cleeland R, Delorenzo WF, Titsworth E, Scholer HJ, Richie R, Brener Z (1967) Antimicrobial Agents and Chemotherapy 1:513–519Google Scholar
  3. 3.
    Cerisola JA (1977) Pan American Health Organisation No 347:35–47Google Scholar
  4. 4.
    Barclay CA, Cerisola JA, Lugones H, Ledesma O, Lopez Silva J, Mouzo G (1978) Prensa Medica Argentina 65:239–244Google Scholar
  5. 5.
    Boainain E (1979) Rev Goiana de Medicina 25:1–60Google Scholar
  6. 6.
    Andrade SG, Magalhaes JB, Pontes AL (1985) Bull World Health Org 63:721–726PubMedGoogle Scholar
  7. 7.
    Goijman SG, Stoppani AOM (1985) Biochem Pharmacol 34:1.331–1.336Google Scholar
  8. 8.
    Goijman SG, Frasch ACC, Stoppani AOM (1985) Biochem Pharmacol 34:1.457–1.461Google Scholar
  9. 9.
    Polak A, Richie R (1978) Annals of Trop Med Parasitol 72:45–54Google Scholar
  10. 10.
    Sampaio RNR, Rocha AA, de Magalhaes AV, Cuba CC, Barreto AC, Raick AN, Marsden PD (1982) Anais Brasileiros de Dermatologia 57:103–105Google Scholar
  11. 11.
    Raaflaub J, Ziegler WH (1979) Arzneim Forsch 29/II:1.611–1.614Google Scholar
  12. 12.
    Workman P, White RAS, Walton MI, Owen LN, Twentyman PR (1984) Br J Cancer 50:291–303PubMedCrossRefGoogle Scholar
  13. 13.
    Raaflaub J (1980) Arzneim Forsch 30/II:2.192–2.194Google Scholar
  14. 14.
    McGreevy PB, Marsden PD (1985) American trypanosomiasis and leishmaniasis. In: Campbell WC, Rew RS (Hrsg.) Chemotherapy of parasitic diseases, Plenum Press, New York London, S. 115–127Google Scholar
  15. 15.
    de Ferreira RCC, de Ferreira LCS (1986) Ciencia e Cultura 38:696–702Google Scholar
  16. 16.
    Texeira AL, Cordoba JC, Maior IS, Solòrzano E (1990) Am J Trop Med Hyg 43:146–158Google Scholar

HA

  1. 1.
    Org Synth Coll Vol 1: 235 (1932) Wiley and Sons, New YorkGoogle Scholar
  2. 2.
    Narang PK, Bird G, Crouthamel WG (1980) J Pharm Sci 69:1384–1387PubMedCrossRefGoogle Scholar
  3. 3.
    Ali SL, Stüber W (1982) Pharm Ztg 127:826–827Google Scholar
  4. 4.
    Übersicht: Kakac B und Vejdelek Z I (1974–1983) Handbuch der photometrischen Analyse organischer Verbindungen S. 360 Verlag Chemie, WeinheimGoogle Scholar
  5. 5.
    Jun HW (1982) Pharm Acta Helv 57:290–292PubMedGoogle Scholar

TR

  1. 1.
    Skutetzky A, Starkenstein E (1914) Die neueren Arzneimittel, 2. Aufl., Verlag von Julius Springer, Berlin, S.230Google Scholar
  2. 2.
    Estler CJ (1986) Med Monatschr Pharm 9:197–210Google Scholar
  3. 3.
    Strichartz GR, Ritchie JM (1987) The action of local anesthetics on ion channels of excitable tissues. In: Strichartz GR (Hrsg.) Handbook of experimental pharmacology, Vol.81, Localanesthetics, Springer-Verlag, Berlin Heidelberg New York London Paris Tokyo Hong Kong, S. 27 ffGoogle Scholar
  4. 4.
    Ritchie JM (1971) Mechanism of action of local anesthetic agents. In: International encyclopedia of pharmacology and therapeutics, Section 8, Vol.1, Local anesthetics, Pergamon Press, Oxford New York Toronto Syndney Braunschweig, S. 115 ffGoogle Scholar
  5. 5.
    Schieper P, Tawfik H (1987) J Pharm Pharmacol 39:517–521CrossRefGoogle Scholar
  6. 6.
    Czinn SJ, Carr HS, Speck WT (1989) J Pediatr Gastroenterol Nutr 9:46–48PubMedGoogle Scholar
  7. 7.
    Tainter ML (1941) Anesthesiology 2:489–502CrossRefGoogle Scholar
  8. 8.
    Hansson E (1971) Absorption, distribution, metabolism and excretion of local anesthetics. In: International encyclopedia of pharmacology and therapeutics, Section 8, Vol.1, Local anesthetics, Pergamon Press, Oxford New York Toronto Sydney Braunschweig, S. 239–260Google Scholar
  9. 9.
    Ritchie JM, Greene NM (1985) Localanesthetics. In: Goodman and Gilman’s, The pharmacological basis of therapeutics, 7. Aufl., MacMillan Publishing Company, New York, S. 302–321Google Scholar
  10. 10.
    Graser GN (1984) Oral Surg Oral Med Oral Pathol 58:42–46PubMedCrossRefGoogle Scholar
  11. 11.
    Lachter J, Jacobs R, Lavya A, Weisler A, Suissa A, Enat R, Eidelmann S (1990) Gastrointest Endosc 36:12–21CrossRefGoogle Scholar
  12. 12.
    Rabin JM, Spitzer M,Dwyer AT, Kaiser IH (1989) Obstet Gynecol 73:1.040–1.044Google Scholar
  13. 13.
    Ruzicka T, Gerstmeier M, Ring J (1987) Z Hautkr 62:455–460PubMedGoogle Scholar
  14. 14.
    Angelini G, Vena GA, Meneghini CL (1985) Contact Dermatitis 12:77–79CrossRefGoogle Scholar
  15. 15.
    Hogan DJ, Hill M, Lane PR (1988) Contact Dermatitis 19:120–124PubMedCrossRefGoogle Scholar
  16. 16.
    Bigby M, Stern RS, Arndt KA (1989) Prim Care 16:713–727PubMedGoogle Scholar
  17. 17.
    Jenni C, Zala L (1980) Schweiz Med Wochenschr 110:124–128PubMedGoogle Scholar
  18. 18.
    Kaidbey KH, Allen H (1981) Arch Dermatol 117:77–79PubMedCrossRefGoogle Scholar
  19. 19.
    Collins JF (1990) Gastroenterology 98:211–213PubMedGoogle Scholar
  20. 20.
    Hall AH, Kulig KW, Rumack BH (1986) Med Toxicol 1:253–260PubMedGoogle Scholar
  21. 21.
    Buckley AB, Newman A (1987) Gastrointest Endosc 33:466–467PubMedCrossRefGoogle Scholar
  22. 22.
    Kolter RL, Hansen-Flaschen J, Casey MP (1989) Thorax 44:234–235CrossRefGoogle Scholar
  23. 23.
    Thomas SG, Philips JB (1989) J Perinatol 9:361–362PubMedGoogle Scholar

FM

  1. 1.
    Bydzovsky V, Bydzovska O (1968) Arch Inst Pasteur Tunis 45:209–217Google Scholar

ak

  1. 1.
    Mar 29, S. 1.355Google Scholar

vB

  1. 1.
    l.BAz,Nr.l09a vom 16.06.1987Google Scholar

GS

  1. 1.
    Damschroder RE, Pederson WD (1955) Organic Synthesis Coll. Vol.III John Wiley and Sons Inc, New York London Sydney, S. 106–108Google Scholar

Et

  1. 1.
    Goeth H, Müller E, Scheffler H (1959) Arneim Forsch 9:622–625Google Scholar
  2. 2.
    Cortat M, Fels P (1987) Arzneim Forsch 37:463–466Google Scholar
  3. 3.
    Weibel MA, Cortat M, Lebek G, LeCotomec IY, Kitler ME, Barcherini G (1987) Arzneim Forsch 37:467–471Google Scholar
  4. 4.
    Kramer A, Nasemann ThRK, Pambor M (1993) Antiseptik aus dermatologischer Indikation. In: Kramer A, Weuffen W, Gröschel D, Heeg P, Hingst V, Lippert H, Rotter M (Hrsg.) Klinische Anwendung von Antiseptika, Springer-Verlag, Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona, S. 387CrossRefGoogle Scholar
  5. 5.
    Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer-Verlag, Jena, S. 49–50Google Scholar

ak

  1. 1.
    Beil Hauptwerk, Bd. 9, S. 179; Erg. Werk 1, Bd. 9, S. 93 Erg. Werk 2, Bd.9, S.157 Erg. Werk 3, Bd.9, Teil 2, S. 1.052 Erg. Werk 4, Bd. 9, Teil 2, S. 717Google Scholar
  2. 2.
    Standardrezepturen (1988), VEB Verlag Volk und Gesundheit Berlin, (14. Aufl.)Google Scholar

Rj

  1. 1.
    Kligman AM, Leyden JJ, Stewart R (1977) Int J Dermatol 16:413–417PubMedCrossRefGoogle Scholar
  2. 2.
    Fulton JE Jr., Farzad-Bakshandeh A, Bradley S (1974) J Cutan Pathol 1:191–200PubMedCrossRefGoogle Scholar
  3. 3.
    Leyden JJ, McGinley K, Mills OH (1980) Topical antibiotics and topical antimicrobial agents in acne therapy. In: Juhlin L, Rorsman H, Strauss JS (Hrsg.) Acne: Dermatology symposia in Lund, Upplands, UppsalaGoogle Scholar
  4. 4.
    Cunliffe WJ, Dodman B, Ead R (1979) Practitioner 220:479–482Google Scholar
  5. 5.
    Cunliffe WJ, Stanton C, Forster RA (1983) Brit J Dermatol 109:577–579CrossRefGoogle Scholar
  6. 6.
    Pierard-Franchimont C, Melotte P, Pierard GE (1984) Brit J Dermatol 110:506CrossRefGoogle Scholar
  7. 7.
    Gloor M, Klump H, Wirth H (1980) Arch Derm Res 267:97–99PubMedCrossRefGoogle Scholar
  8. 8.
    Mills OH, Kligman AM (1975) Assay of comedolytic agents in the rabbit ear. In: Maibach H (Hrsg.) Animal models in dermatology, Churchill Livingstone, Edinburgh, S. 176–183Google Scholar
  9. 9.
    Plewig G (1980) Fette, Seifen, Anstrichmittel 82:537–541CrossRefGoogle Scholar
  10. 10.
    Nacht S, Yeung D, Beasley JN Jr., Anjo MD, Maibach HI (1981) J Am Acad Dermatol 4:31–34PubMedCrossRefGoogle Scholar
  11. 11.
    Yeung D, Nacht S, Bucks D, Maibach HI (1983) J Am Acad Dermatol 9:920–924PubMedCrossRefGoogle Scholar
  12. 12.
    Schutte H, Cunliffe WJ, Forster RA (1982) Brit J Dermatol 106:91–94CrossRefGoogle Scholar
  13. 13.
    Cunliffe WJ, Holland KT (1981) Acta Derm Venerol 61:267–269PubMedGoogle Scholar
  14. 14.
    Kessler HJ (1980) Mykosen 23:285–289PubMedCrossRefGoogle Scholar
  15. 15.
    Burke B, Eady EA, Cunliffe WJ (1983) Brit J Dermatol 108:199–204CrossRefGoogle Scholar
  16. 16.
    Tucker SB, Tausend R, Cochran R, Flamigan SA (1984) Brit J Dermatol 110:487–492CrossRefGoogle Scholar
  17. 17.
    Eaglestein WH (1968) Arch Dermatol 97:527CrossRefGoogle Scholar
  18. 18.
    Melski JW, Arndt KA (1980) New Engl J Med 302:503–506PubMedCrossRefGoogle Scholar
  19. 19.
    Morillas IM, Martinez AA, Sanchez Lozano JL (1987) Contact Dermat 16:232–233CrossRefGoogle Scholar
  20. 20.
    Harvey SC (1980) Antiseptics and disinfectants; fungicides, ectoparasiticides. In: Goodman and Gilman’s: The pharmacological basis of therapeutics, 6th ed., Macmillan Publ, New York, S. 974Google Scholar
  21. 21.
    Bolton L, Oleniacz W, Constantine B, Kelliher BO, Jensen D, Means B, Rovee D (1985) Repair and antibacterial effects of topical antiseptic agents in vivo. In: Maibach HI, Lowe NJ (Hrsg.) Models in Dermatology Vol 2, Karger Basel, S. 145–158Google Scholar
  22. 22.
    Slaga TJ, Klein-Szanto AJP, Triplett LL, Yotti LP (1981) Science 213:1023PubMedCrossRefGoogle Scholar
  23. 23.
    Kurokawa Y, Takamura N, Matsushida Y, Imazawa T, Hayashi Y (1984) Cancer Letters 24:299–304PubMedCrossRefGoogle Scholar
  24. 24.
    Cartwright RA, Hughes BR, Cunliffe WJ (1988) Brit J Dermatol 118:239–242CrossRefGoogle Scholar

ak/Gs

  1. 1.
    Tretter Jr. (Chas, Pfizer & Co., Inc.) Belg Pat 618,741 (1962, 1961), zit. nach CA (1963) 59:10007eGoogle Scholar
  2. 2.
    Brossi A, Lindler H Walter M, Schnider O (1958) Helv Chim Acta 16:119–139CrossRefGoogle Scholar
  3. 3.
    Tretter Jr. (Chas, Pfizer & Co., Inc.) US PAt 3,053,845 (1962, 1961), zit. nach CA(1963) 58:3404gGoogle Scholar
  4. 4.
    Szantay C, Novak L, Sohar P, Acta Chim Acad Sci Hung (1968) 57:335–343, zit. nach CA(1969) 70:19897qGoogle Scholar
  5. 5.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs. Pharmaceutical Press, LondonGoogle Scholar

ME

  1. 1.
    SzantayC, Novak L, Sohar P, Acta Chim Acad Sci Hung (1968) 57:335–343; CA (1969) 70:19.897qGoogle Scholar

ME

  1. 1.
    Pan SY, Scriabine A, McKersie DE, McLamore WM (1960a) J Pharmacol Exp Ther 128:122–130Google Scholar
  2. 2.
    Leibmann KC, Alford D, Boudet RA (1961) J Pharmacol Exp Ther 131:271–274Google Scholar
  3. 3.
    Peters G, Roch-Ramel F (1969) Thiazide diuretics and related drugs. In: Eichler O, Farah A, Herken H, Welch AD (Hrsg.) Handb Exp Pharmacol, Springer, Berlin Heidelberg New York 24:257–385Google Scholar
  4. 4.
    Welling GP (1986) Biopharmac Drug Disp 7:501–535CrossRefGoogle Scholar

Oß/al

  1. 1.
    Müller-Peddinghaus, R, Wurl M, Lenoir G, Houben A, Remache J (1987) Arzneim Forsch 37(I):601–605Google Scholar
  2. 2.
    Jansen JWCM (1987) Arzneim Forsch 37(I):626–628Google Scholar
  3. 3.
    Catanese B, Lisciani R, Piccinelli D (1969) Biochem Pharmacol 18:1.707–1.710CrossRefGoogle Scholar
  4. 4.
    Lisciani R, Barcellona PS, Silvestrini B (1968) Eur J Pharm 3:157–162CrossRefGoogle Scholar
  5. 5.
    Silvestrini B, Garan A, Pozzatti C, Cioli V, Catanese B (1969) Arch Int Pharmacodyn 163:61–69Google Scholar
  6. 6.
    Catanese B, Grasso A, Silvestrini B (1966) Arneim Forsch 16:1.354–1.357Google Scholar
  7. 7.
    Andersson K, Larsson H (1974) Arneim Forsch 24:1.686–1.688Google Scholar
  8. 8.
    Bentivoglio G, Diani F (1981) Clin Exp Obstet Gynecol 8:103–110PubMedGoogle Scholar
  9. 9.
    Köppel C, Tenczer J (1985) Arzneim Forsch 35(I):634–644Google Scholar

Sm/KA

  1. 1.
    Mar 29, S. 1.356Google Scholar
  2. 2.
    Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, BerlinGoogle Scholar

vB

  1. 1.
    Meneghini CL, Vena GA, Angelini G (1982) Contact Dermatitis 8:428CrossRefGoogle Scholar

Gs

  1. 1.
    Steinegger E, Hänsel R (1972) Lehrbuch der Pharmakognosie, 3. Aufl., Springer-Verlag, Berlin, S. 441Google Scholar

bg

  1. 1.
    Mar 29, S. 1.546Google Scholar

vB

  1. 1.
    Eigene MessungGoogle Scholar

TA

  1. 1.
    Beilsteins Handbuch der Chemie E II 10:122; E IV 10:573, Springer Verlag, HeidelbergGoogle Scholar
  2. 2.
    DDR Pat. (1959) 11.639, zit. nach CA (1960) 54:19.601fGoogle Scholar
  3. 3.
    DB Pat (1954) 919.467, zit. nach CA (1958) 53:14.685dGoogle Scholar
  4. 4.
    DB Pat. (1957) 1005.948, zit. nach CA (1959) 53:15.012cGoogle Scholar
  5. 5.
    Beilsteins Handbuch der Org. Chemie: 10:197; EI 10:86; EII 10:118; EIII 10:448; EIV 565, Springer Verlag, HeidelbergGoogle Scholar
  6. 6.
    Kuhnert-Brandstätter M (1971) Thermomikroscopy in the Analysis of Pharmaceuticals, Pergamon Press, Oxford, S. 96Google Scholar
  7. 7.
    Kiemisch W, von Hodenberg A (1985) J High Resolut Chromatogr Chromatogr Commun 8:37–38CrossRefGoogle Scholar
  8. 8.
    Patrunky M, Wollmann H (1982) Zentralbl Pharm Pharmakother Laboratoriumsdiagn 121:851–856Google Scholar

hh

  1. 1.
    Macht DI (1953) J Pharmacol Exp Ther 21:443–455Google Scholar
  2. 2.
    Brock N, Kühas E, Lorenz D (1952) Arzneim Forsch 2:165–168Google Scholar
  3. 3.
    Funke ABH, Ernsting MJE, Rekker RF, Nauta WT (1953) Arzneim Forsch 3:503–506Google Scholar
  4. 4.
    Gabka J, Schwietzer CH (1974) Therapie der Gegenwart 11:1898–1910Google Scholar
  5. 5.
    Kluger L, Zielnievicz J (1978) Ärztliche Praxis 68:1894–1897Google Scholar
  6. 6.
    Schütz HW (1977) Beitr Gericht Med 35:85–87Google Scholar

KC

  1. 1.
    Spezifikation der Fa. E. MerckGoogle Scholar

FB

  1. 1.
    Reynolds JEF (1989) Martindale. The extra pharmacopoeia 29th ed., Pharmaceutical Press, London, S.1506Google Scholar
  2. 2.
    Holzmann H, Lachner H 81969) Arch Klin Exp Dermatol 234:261–272PubMedGoogle Scholar
  3. 3.
    Tronnier H (1960) Berufsdermatosen 8:25–46Google Scholar
  4. 4.
    Gugler R (1978) Clin Pharmacokin 3:425–439CrossRefGoogle Scholar
  5. 5.
    Schmidt G (1989) Rheumatische Erkrankungen. In: Fülgraff G, Palm D (Hrsg.) Pharmakotherapie-klinische Pharmakologie, 7. Aufl., Fischer, Stuttgart, S. 213–214Google Scholar
  6. 6.
    Helwig H, Otto HH (1988) Arzneimittel, ein Handbuch für Ärzte und Apotheker, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 14–62Google Scholar

Gs

  1. 1.
    Anonymous Author (1987) Microbiology and Pharmacokinetics of Parenteral Penicillins, Brochure der Hoffman-LaRoche Inc USA, S. 1–34Google Scholar
  2. 2.
    Monographie: Benzylpenicillin, BAz Nr.104 vom 7.6.1990, Jg. 42, 2.934Google Scholar
  3. 3.
    Bergan T, Oydwin B (1974) Chemotherapy (Basel) 20:263–279CrossRefGoogle Scholar
  4. 4.
    Barza M, Weinstein L (1976) Clin Pharmacokinet 1:297–308PubMedCrossRefGoogle Scholar
  5. 5.
    Barling RWA, Selkon JB (1978) J Antimicrob Chemother 4:203–227PubMedCrossRefGoogle Scholar

CW

  1. 1.
    Irwin WJ, Hempenstall JM, Wan Po A, Andrews AH (1984) J Chromatogr 287:85–96PubMedCrossRefGoogle Scholar

HO

  1. 1.
    Mar 29, S. 129Google Scholar

vB

  1. 1.
    Martin JL, Duncombe RE, Shaw WHC (1975) Analyst 100:243–248PubMedCrossRefGoogle Scholar
  2. 2.
    Nachtmann F, Gstrein K (1982) J Chromatogr 236:461–468CrossRefGoogle Scholar
  3. 3.
    Pospisilova B, Simkova M, Kubes J (1986) Pharmazie 41:705–708PubMedGoogle Scholar
  4. 4.
    Irwin WJ, Hempenstall JM, Li Wan Po A, Andrews AH (1984) J Chromatogr 287:85–96PubMedCrossRefGoogle Scholar
  5. 5.
    Stuber B (1982) Pharm Acta Helv 57:293–294PubMedGoogle Scholar
  6. 6.
    Rizk M, Walash MI, Abou-Ouf AA, Belal F (1981) Anal Lett 14:1407–1417CrossRefGoogle Scholar

HO

  1. 1.
    Monographie: Benzathin-Benzylpenicillin, BAz Nr.77 vom 24.4.1990, Jg. 42, S. 2.178–2.179Google Scholar
  2. 2.
    Ginsburg CM, McCracken GH Jr., Zweighaft TC (1982) Pediatrics 69:452–454PubMedGoogle Scholar
  3. 3.
    Collart P, Poitevin M, Minovanovic A, Herlin A, Durel J(180) Br J Vener Dis 56:355–362Google Scholar
  4. 4.
    Kaplan JM, McCracken GH Jr. (1973) J Ped 82:1.069–1.072Google Scholar
  5. 5.
    Stollerman GH, Rusoff JH, Hirschfeld I (1955) New Engl J Med 252:787–792PubMedCrossRefGoogle Scholar
  6. 6.
    Hassel TA, Stuart KL (1974) Br Med J 2:39–40CrossRefGoogle Scholar

cw

  1. 1.
    Gerold W, Heinisch G (1981) Pharmazie 36:347–348Google Scholar
  2. 2.
    Hou JP, Poole JW (1972) 61:1594–1598Google Scholar
  3. 3.
    Pospisilova B, Simkova M, Kubes J (1986) Pharmazie 41:705–708PubMedGoogle Scholar

HO

  1. 1.
    Pokorny M, Vitezic N, Japelj M (1973) J Chromatogr 77:458–460PubMedCrossRefGoogle Scholar
  2. 2.
    Martin JL, Duncombe RE, Shaw WHC (1975) Analyst 100:243–248PubMedCrossRefGoogle Scholar
  3. 3.
    Bundsgaard H, Ilver K (1972) J Pharm Pharmac 24:790–794CrossRefGoogle Scholar
  4. 4.
    Roksvaag PO, Brummenaes HJ, Waaler T (1979) Pharm Acta Helv 54:180–185Google Scholar
  5. 5.
    Ullmann U, Bielenberg U (1986) Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie, Bd. 4–7, Futuramed Verlag, MünchenGoogle Scholar
  6. 6.
    Bishop E, Hussein W (1984) Analyst 109:913–921CrossRefGoogle Scholar
  7. 7.
    Khier AA, Blaschke G, El Sadek M (1984) Anal Lett 17:1667–1675CrossRefGoogle Scholar

HO

  1. 1.
    BAz, Nr. 242a vom 28.12.1988 i.d.F v. BAz Nr. 146 v. 8.8.1989Google Scholar

GS

  1. 1.
    Prosser HJ, Groffman DM, Wilson AD (1982) J Dent Res 61:1.431–1.435Google Scholar
  2. 2.
    Fisher FJ (1977) Brit dent J 143:231–235Google Scholar

Me

  1. 1.
    l. USP 2.918.401, DBP 1.117.600, zit. nach CA (1962) 56:14165iGoogle Scholar

sb/Ni

  1. 1.
    James DM, Gilles HM (1985) Human antiparasitic drugs, pharmagology and usage. J. Wiley and Sons, Chichester New York Brisbane Toronto Singapore, S. 197–217Google Scholar
  2. 2.
    Van den Bossche H (1980) Biochem Pharmacol 29:1.981–1.990Google Scholar
  3. 3.
    Broome AWJ (1962) Mechanism of anthelmintic action with particular reference to drugs affecting neuromuscular activity. In: Goodwin IG, Nimmo-Smith RM (Hrsg.) Drugs, parasites and hosts, Churchill, London, S. 43–61Google Scholar
  4. 4.
    Del Castillo J (1969) Pharmacology of nematoda. In: Florkin M, Scheer BT (Hrsg.) Zoology, S. 521–554Google Scholar
  5. 5.
    Botero D, Castano A (1973) Am J Trop Med Hyg 22:45–52PubMedGoogle Scholar
  6. 6.
    Botero D (1986) Nematode infections of man, intestinal infections. In: Campbell WC, Rew RS (Hrsg.) Chemotherapy of parasitic diseases, Plenum Press, New York London, S. 267–276CrossRefGoogle Scholar

ha

  1. 1.
    Barrett Comp. (1922) US-Pat. Nr. 1491465, zit. nach CA (1924) 18:1836Google Scholar
  2. 2.
    Dewey BT, Shasky HG (1941) J Amer Chem Soc 63:3526–3527CrossRefGoogle Scholar
  3. 3.
    Stempel GH, Schaffei GS (1942) J Amer chem Soc 64:470–471CrossRefGoogle Scholar

Et

  1. 1.
    Umezawa H, Aoyagi T, Suda H, Hamada M, Takeuchi T (1976) J Antibiotics 29:97–101CrossRefGoogle Scholar
  2. 2.
    Pearson WH, Hines JV (1989) J Org Chem 54:4.235–4.237Google Scholar
  3. 3.
    Kobayashi S, Toshiyuki I, Ohno M (1984) Tetrahedron Lett 25:5.079–5.082Google Scholar
  4. 4.
    Ishida J, Yamaguchi M, Kai M, Ohkura Y, Nakamura M (1984) J Chromatogr 305:381–389PubMedGoogle Scholar
  5. 5.
    Nakada M, Arai S, Ohtaki H, Terada T (1987) Kagaku Ryoho no Ryoiki 3:1.691–1.697; CA 108:26.888uGoogle Scholar

us

  1. 1.
    Saito M, Takegoshi K, Aoyagi T, Umezawa H, Nagai Y (1978) Cell Immunol 40:247–262PubMedCrossRefGoogle Scholar
  2. 2.
    Müller WEG, Zahn RK, Arendes J, Munch N, Umezawa H (1979) Biochem Pharmacol. 28:3131–37PubMedCrossRefGoogle Scholar
  3. 3.
    Schorlemmer HU, Bosslet K, Sedlacek HH (1983) Cancer Res 43:4.148–4.153Google Scholar
  4. 4.
    Noma T, Klein B, Cupissol D, Yata J, Serrou B (1984) Int J Immunopharmacol 6:87–92PubMedCrossRefGoogle Scholar
  5. 5.
    Blazsek I, Comisso M, Misset JL (1991) Biomed Pharmacother 45:81–86PubMedCrossRefGoogle Scholar
  6. 6.
    Okamura S, Omori F, Haga K, Baba H, Sugimachi K, NihoY(1990) Acta Oncol 29:795–797PubMedCrossRefGoogle Scholar
  7. 7.
    Yamazaki T, Sugiyama K, Ichihara K (1991) Biomed Pharmacother 45:105–112PubMedCrossRefGoogle Scholar
  8. 8.
    Mathe G (1991) Biomed Pharmacother 45:49–54PubMedCrossRefGoogle Scholar
  9. 9.
    Suda H, Avoyagi T, Takeuchi T, Umezawa H (1976) Arch Biochem Biophys 177:196–200PubMedCrossRefGoogle Scholar
  10. 10.
    Umezawa H, Aoyagi T, Suda H, Hammada M, Takeuchi T. (1976) J Antibiot 29:97–99PubMedCrossRefGoogle Scholar
  11. 11.
    Leyhausen G, Schuster DK, Vaith P, Zahn RK, Umezawa H, Falke D, Müller WEG (1983) Biochem Pharmacol 32:1.051–1.057CrossRefGoogle Scholar
  12. 12.
    Peppers SC, Lenney JF (1988) Biol Chem Hoppe Seyler 369:1.281–1.286CrossRefGoogle Scholar
  13. 13.
    Orning L, Krivi G, Fitzpatrick FA (1991) J Biol Chem 266:1.375–1.378Google Scholar
  14. 14.
    Dickneite G, Kaspereit F, Sedlacek HH (1984) Infect Immun 44:168–174PubMedGoogle Scholar
  15. 15.
    Harada Y, Kajiki A, Higachi K, Ishibashi T, Takamoto M(1983) JAntibiot 36:1.411–1.414CrossRefGoogle Scholar
  16. 16.
    Jarstrand C, Blomgren H (1982) J Clin Lab Immunol 7:115–118PubMedGoogle Scholar
  17. 17.
    Abe F, Schneider M, Black PL, Talmadge JE (1989) Cancer Immunol Immunother 29:231–236PubMedCrossRefGoogle Scholar
  18. 18.
    Tomita Y, Katsura T, Okano T, Inui K, Hori R (1990) J Pharmacol Exp Ther 252:859–862PubMedGoogle Scholar
  19. 19.
    Abe F, Alvord G, Koyama M, Matsuda A, Talmadge JE (1989) Cancer Immunol Immunother 28:29–33PubMedCrossRefGoogle Scholar
  20. 20.
    Abe F, Kuramochi H, Takahashi K, Ishizuka M, Takeuchi T (1988) J Antibiot 41:1.862–1.867CrossRefGoogle Scholar
  21. 21.
    Uzuka Y,SaitoY(1991) Biomed Pharmacother 45:87–93CrossRefGoogle Scholar
  22. 22.
    Ota K (1991) Biomed Pharmacother 45:55–60PubMedCrossRefGoogle Scholar
  23. 23.
    Ota K, Ogawa N (1990) Biomed Pharmacother 44:93–101PubMedCrossRefGoogle Scholar
  24. 24.
    Ota K, Kurita S, Yamada K, Masaoka T, Uzuka Y, Ogawa N (1986) Cancer Immunol Immunother 23:5–10PubMedCrossRefGoogle Scholar
  25. 25.
    Furuhashi M, Mizutani S, Kurauchi O, Kasugai M, Tomoda Y (1989) Horm Metab Res 21:366–368PubMedCrossRefGoogle Scholar

vB

  1. 1.
    Devin J, Hunter RF, Williams NE (1945) Biochem J 39:5–6Google Scholar
  2. 2.
    Pouchert CJ (1981) The Aldrich Library of Infrared Spectra, Aldrich Chemical Company, USAGoogle Scholar
  3. 3.
    Isler O, Gutmann H, Solms U (1971) Carotinoids, Birkhäuser Verlag, Basel StuttgartGoogle Scholar
  4. 4.
    Englert G (1975) Helv Chim Acta 58:2367–2390PubMedCrossRefGoogle Scholar
  5. 5.
    Reagenzienkatalog Merck 1990/91Google Scholar

  1. 1.
    Bäßler KH, Grühn E, Loew D, Pietrzik K (1992) Vitamin-Lexikon, Fischer, StuttgartGoogle Scholar
  2. 2.
    Friedrich W (1987) Betacarotin. In: Friedrich W (Hrsg.) Handbuch der Vitamine, Urban & Schwarzenberg, München Wien BaltimoreGoogle Scholar
  3. 3.
    Deutsche Gesellschaft für Ernährung (1985) Empfehlungen zur Nährstoffzufuhr, Umschau, FrankfurtGoogle Scholar

KP

  1. 1.
    Ardey RE, Moffat AC (1981) J Chromatogr 220:195–252CrossRefGoogle Scholar
  2. 2.
    Moffat AC (1986) Clarke’s Isolation and Identification od Drugs, The Pharmaceutical Press, London, S. 190Google Scholar
  3. 3.
    Douglas JF, Hohing TL (1978) Experientia 34:499–500PubMedCrossRefGoogle Scholar
  4. 4.
    Jane I, McKinnon A, Flanagan RJ (1985) J Chromatogr 323:191–225PubMedCrossRefGoogle Scholar

WE

  1. 1.
    Unemoto H, Sasa M, Takaori, S, Ito J, Matsuoka I (1982) Arch Otorhinolaryngol 236:229–236PubMedCrossRefGoogle Scholar
  2. 2.
    Arrang JM, Garbarg M, Quach TT, Dam Trung Tuong M, Yeramian E, Schwartz JC (1985) Eur J Pharmacol 111:73–84PubMedCrossRefGoogle Scholar
  3. 3.
    Chan TB, Eiser N, Shelton D, Rees PJ (1987) Br J Dis Chest 81:260–267PubMedCrossRefGoogle Scholar
  4. 4.
    Gater PR, Webber SE, Gui GP, Jordan CC, Hayes NA, Ashford JJ, Foreman JC (1986) Agents Actions 18:342–350PubMedCrossRefGoogle Scholar
  5. 5.
    Bandtlow O (1980) Fortschr Med 98:1.705–1.707Google Scholar
  6. 6.
    Meyer ED (1985) Laryngol Rhinol Otol (Stuttg) 64:269–272CrossRefGoogle Scholar
  7. 7.
    Müller H, Buttkus R (1983) Laryngol Rhinol Otol (Stuttg) 62:151–153CrossRefGoogle Scholar
  8. 8.
    Oosterveld WJ (1984) J Laryngol Otol 98:37–41PubMedCrossRefGoogle Scholar
  9. 9.
    Bertrand RA (1982) Adv Otorhinolaryngol 28:104–110PubMedGoogle Scholar
  10. 10.
    Petermann W, Mulch G (1982) Fortschr Med 100:431–435PubMedGoogle Scholar
  11. 11.
    Deering RB, Prescott P, Simmons RL, Downey LJ (1986) Curr Med Res Opin 10:209–214PubMedCrossRefGoogle Scholar
  12. 12.
    Elbaz P (1988) Acta Otolaryngol Suppl (Stockh) 460:143–148CrossRefGoogle Scholar
  13. 13.
    Kluyskens P, Lambert P, D’Hooge D (1990) Ann Otolaryngol Chir Cervicofac 107:Suppl 1,11–19Google Scholar
  14. 14.
    Martini A, De Domenico F (1990) Ann Otolaryngol Chir Cervicofac 107:Supp 1,20–27PubMedGoogle Scholar

  1. 1.
    Clarke EGC (1975) Isolation and Identification of Drugs, Bd. II, The Pharmaceutical Press, LondonGoogle Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, LondonGoogle Scholar
  3. 3.
    Pouchert CJ, Campell Jr. (1974) The Aldrich Library of NMR-Spectra Aldrich Chemical Company Inc., Milwaukee, Wisconsin, USAGoogle Scholar

WE

  1. 1.
    Moffat, AC (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs Pharmaceutical Press, LondonGoogle Scholar
  2. 2.
    Edsall J T (1943) J Am Chem Soc 65:1767–1772CrossRefGoogle Scholar
  3. 3.
    Dasgupta B, Basu K (1970) Experienta 26(5):477–478CrossRefGoogle Scholar

QO

  1. 1.
    Rafter JE, Chalmers RA, Iles RA (1989) Biochem Soc Trans 17:1.130–1.131Google Scholar
  2. 2.
    Gäbler H (1971) Therd Gegenw 110:505–514Google Scholar
  3. 3.
    Braier L (1978) Nouv Rev Fr Hematol 20:63–66PubMedGoogle Scholar
  4. 4.
    Barak AJ, Tuma DJ (1983) Life Sci 32:771–774PubMedCrossRefGoogle Scholar
  5. 5.
    Best CH, Ridout JH, Lucas CC (1969) Can J Physiol Pharmacol 47:73–79PubMedCrossRefGoogle Scholar
  6. 6.
    Babucke G, Sarre H (1973) Med Klin 1.968:1.109–1.113Google Scholar
  7. 7.
    Hilt G, Tuzin P (1973) Med Mschr 27:322–325PubMedGoogle Scholar
  8. 8.
    Kandziora J (1976) ZFA Stuttgart 52:1.561–1.563Google Scholar
  9. 9.
    Semmler F (1977) Ther Gegenw 116:2.113–2.124Google Scholar
  10. 10.
    Bartholomew DW, Batshaw ML, Allen RH, Roe CR, Rosenblatt D, Valle DL, Francomano CA (1988) J Pediatr 112:32–39PubMedCrossRefGoogle Scholar
  11. 11.
    Wilcken DEL, Dudman NPB, Tyrrell PA (1985) Metabolism 34:1.115–1.121CrossRefGoogle Scholar
  12. 12.
    Ammon HPT (1981) Arzneimittelneben-und Wechselwirkungen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 364Google Scholar
  13. 13.
    Ghoz EH, Freed WJ (1985) Pharmacol Biochem Behav 22:635–640PubMedCrossRefGoogle Scholar
  14. 14.
    Leiper JB, Maughan RJ (1989) Scand J Gastroenterol 24:1.089–1.094CrossRefGoogle Scholar
  15. 15.
    Munck BG (1966) Biochim Biophys Acta 120:97–103PubMedCrossRefGoogle Scholar
  16. 16.
    Ikeda GJ, Miller E, Sapienza PP, Michel TC, Sager AO (1985) Food Chem Toxicol 23:609–614PubMedCrossRefGoogle Scholar
  17. 17.
    Wolff SD, Stanton TS, James SL, Balaban RS (1989) Am J Physiol 257:F676–F681PubMedGoogle Scholar
  18. 18.
    Schirmer JP Jr., Tieckelmann H, Guthrie R (1965) Experientia 21:448–449PubMedCrossRefGoogle Scholar
  19. 19.
    Yancesy PH, Burg MB (1989) Am J Physiol 257:F602–607Google Scholar

PK

  1. 1.
    Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:2–10CrossRefGoogle Scholar
  2. 2.
    Rohdewald P, Möllmann HW, Hochhaus G (1984) Atemw Lungenkrkh 10:484–589Google Scholar
  3. 3.
    Miesfeld RL (1990) Am Rev Respir Dis 141 S2:11–17Google Scholar
  4. 4.
    Hahn HL (1990) Wirkungsmechanismen der Glukokortikoide bei Asthma, bronchialer Entzündungsreaktion und Hyperreaktivität. In: Nolte D (Hrsg.) Glukokortikoide bei obstruktiven Atemwegserkrankungen, de Gruyter, Berlin New York, S. 23–56Google Scholar
  5. 5.
    Schleimer RP (1990) Am Rev Respir Dis 141 S2:59–69Google Scholar
  6. 6.
    Bowen DL, Fauci AS (1988) Adrenal Corticosteroids. In: Gallin JI, Goldstein M, Snyderman R (Hrsg.) Inflammation: basic principles and clinical correlates, Raven Press, New York, S. 877–896Google Scholar
  7. 7.
    Haack D, Maser-Gluth C, Meier G, Marsiske C (1986) Atemw Lungenkrkh 12:93–98Google Scholar
  8. 8.
    Marwah RJ, Pickup ME, Al-Sharkarchi H, Dixon JS, Lowe Jr., Bird HA, Wright V (1982) Eur J Clin Pharmacol 23:321–325PubMedCrossRefGoogle Scholar
  9. 9.
    Ballard PL (1979) Delivery and transport of glucocorticoids to target cells. In: Baxter JD, Rousseau GG (Hrsg.) Glucocorticoid hormone action, Springer, Berlin Heidelberg New York, S. 25–48CrossRefGoogle Scholar
  10. 10.
    Pauwels R, Straeten M van der (1982) Eur J Respir Dis 63 S122:83–85Google Scholar
  11. 11.
    Butler J, Gray CH (1970) J Endocrinol 46:379–390PubMedCrossRefGoogle Scholar
  12. 12.
    Kaiser H (1987) Cortisonderivate in Klinik und Praxis, Thieme, Stuttgart New YorkGoogle Scholar
  13. 13.
    Melby JC (1977) Ann Rev Pharmacol Toxicol 17:511–527CrossRefGoogle Scholar
  14. 14.
    Müller W (1981) Therapiewoche 31:6.258–6.265Google Scholar
  15. 15.
    Laasko L (1981) Curr Ther Res 30:19Google Scholar
  16. 16.
    Jubiz W, Meikle AW (1979) Drugs 18:113–121PubMedCrossRefGoogle Scholar

GM

  1. 1.
    Derendorf H, Möllmann H, Grüner A, Haack D, Gyselby G (1986) Clin Pharm Ther 39:313–317CrossRefGoogle Scholar
  2. 2.
    Gless KH, Klee HR, Vescei P, Weber M, Haack D, Lichtwald K (1981) Dtsch Med Wochenschr 106:704–707PubMedCrossRefGoogle Scholar
  3. 3.
    Derendorf H, Möllmann HW, Barth J (1990) Akt Rheumatol 15:145–153CrossRefGoogle Scholar

vB/GM

  1. 1.
    Mar 29, S. 468Google Scholar

EH

  1. 1.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, LondonGoogle Scholar
  2. 2.
    Corder CN et al (1975) J Pharm Sci 64(5):785–788PubMedCrossRefGoogle Scholar
  3. 3.
    Hengstmann JH et al (1974) Anal Chem 46(l):34–39PubMedCrossRefGoogle Scholar
  4. 4.
    Shipe Jr. et al (1983) Clin Chem 29:1793–1795PubMedGoogle Scholar

LD

  1. 1.
    Manoury PMJ, Cavero IAG, Majer H, Giudicelli PRL (Synthelabo S.A.) DBP 2,649,605 (1977, 1975), zit. nach CA (1977) 87:134543]’Google Scholar

ME

  1. 1.
    Beresford R, Heel RC (1986) Drugs 31:6–28PubMedCrossRefGoogle Scholar
  2. 2.
    Boudot J, Cavero I, Fenard S, Lefevre-Borg F, Manoury P, Roach AG (1979) Brit J Pharmacol 66:445PGoogle Scholar
  3. 3.
    Riddell JG, Shanks RG (1985) Brit J Clin Pharmacol 19:138PCrossRefGoogle Scholar
  4. 4.
    Taylor E, Trembath P, Warrington S (1981) Brit J Clin Pharmacol 12:201–209Google Scholar
  5. 5.
    Biamino G (1983) In: Morselli PL (Hrsg.) LERS Monograph Series 1, Raven Press, New York, S. 251–255Google Scholar
  6. 6.
    Frisk-Holmberg M (1983) Betaxolol in hypertension at rest and during exercise. In: Morselli PL (Hrsg.) LERS Monograph Series 1, Raven Press, New York, S. 303–308Google Scholar
  7. 7.
    Pathé M, Schwartz J (1985) Therapie 40:209–212PubMedGoogle Scholar
  8. 8.
    Warrington S,Turner P, Kilborn J, Bianchetti G, Morselli P (1980) Brit J Clin Pharmacol 10:449–452CrossRefGoogle Scholar
  9. 9.
    Bianchetti G, Padovani P, Thiercelin J, Thenot J, Morselli P (1983) In: Morselli PL (Hrsg.) LERS Monograph Series 1, Raven Press, New York, S. 123–131Google Scholar
  10. 10.
    Bianchetti G, Thiercelin JF, Thenot JP (1986) Eur J Clin Pharmacol 31:231–233PubMedCrossRefGoogle Scholar
  11. 11.
    Weber S (1985) J Amer Med Ass (France) 10 (99, Suppl):21–23Google Scholar
  12. 12.
    Dijan J (1985) Brit J Clin Practice 39:188–191Google Scholar

EH

  1. 1.
    Badische Anilin & Soda-Fabrik (1954) Brit 708389, zit. nach CA (1955) 49:11019fGoogle Scholar
  2. 2.
    Hanna GM, Lau-Cam CA (1987) J Assoc Off Anal Chem 70:557–559PubMedGoogle Scholar
  3. 3.
    Taylor EH (1964) Llodia 27:96–99Google Scholar
  4. 4.
    Chatten LG, Napper AC, Barry PJ (1967) J Pharm Sci 56:834–838PubMedCrossRefGoogle Scholar
  5. 5.
    Yutaka A, Masami T, Kazuko M (1986) Bunseki Kagaku 35:147–150, zit. nach CA (1986) 104:230571gCrossRefGoogle Scholar
  6. 6.
    Miller BE, Danielson ND, Katon JE (1988) Appl Spectrosc 42:401–405CrossRefGoogle Scholar
  7. 7.
    Kuhnert-Brandstätter M, Geiler M, Wurian I (1980) Sci Pharm 48:250–258Google Scholar
  8. 8.
    Ebel S (1977) Handbuch der Arzneimittel-Analytik, 1. Aufl., Verlag Chemie, Weinheim, S. 335Google Scholar
  9. 9.
    Beckmann R (1966) Arzneim Forsch 16:910–918Google Scholar
  10. 10.
    Daldrup T, Susanto F, Michalke P (1981) Fresenius Z Anal Chem 308:413–427CrossRefGoogle Scholar
  11. 11.
    Daldrup T, Michalke P, Boehme W (1982) Chromatography Newsl 10:1–7Google Scholar
  12. 12.
    Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor AulendorfGoogle Scholar

SH

  1. 1.
    Monk JP, Todd PA (1987) Drugs 33:539–576PubMedCrossRefGoogle Scholar
  2. 2.
    Paoletti R, Franceschini G, Sirtori CR (1983) Am J Cardiol 52-.21B–27BPubMedCrossRefGoogle Scholar
  3. 3.
    Arntz HR, Klemens UH, Lang PD, Vollmar J (1978) Med Klinik 73:1.731–1.737Google Scholar
  4. 4.
    Bolzano K, Klempler F, Schellenberg B, Schlierf G (1979) Eine vergleichende Studie von Bezafibrat und Clofibrat bei Patienten mit Hyperlipoproteinämie vom Typ IIb und IV. In: Greten H, Lang PD, Schettler G (Hrsg.) Lipoproteine und Herzinfarkt, Gerhard Witzstrock Verlag, Baden-Baden, S. 134–136Google Scholar
  5. 5.
    Olsson AG, Rössner S, Walldius G, Carlson LA, Lang PD (1977) Atherosclerosis 79:279–287CrossRefGoogle Scholar
  6. 6.
    Mordasini R, Riesen W, Oster P, Keller M, Middelhoff G, Lang PD (1981) Atherosclerosis 40:153–158PubMedCrossRefGoogle Scholar
  7. 7.
    Martini S, Valerio G, Fellin R, Baggio G, Gasparotto A, Baiocchi MR, Baldo G, Crepaldi G (1982) Curr Ther Res 31:354–361Google Scholar
  8. 8.
    Sommariva D, Tirrito M, Bonfiglioli D, Poliaghi I, Branchi A, Cabrini E (1986) Int J Clin Pharm Res VI:249–253Google Scholar
  9. 9.
    Vessby B, Lithell H, Hellsing K, Östlund-Lindqvist AM, Gustaffson IB, Boberg J, Ledermann H (1980) Atherosclerosis 37:257–269PubMedCrossRefGoogle Scholar
  10. 10.
    Patsch Jr., Gotto AM Jr., Olivecrona T, Eisenberg S (1978) Proc Natl Acad Sci 75:4.519–4.523CrossRefGoogle Scholar
  11. 11.
    Berndt J, Gaumert R, Still J (1978) Atherosclerosis 30:147–152PubMedCrossRefGoogle Scholar
  12. 12.
    Stegmeier K, Stork H, Lenz H, Leuschner F, Liede V (1980) Pharmacology and mode of action of bezafibrate in animals. In: Greten H, Lang PD, .Schettler G (Hrsg.) Lipoproteins and coronary heart disease, Gerhard Witzstrock Publishers, New York Baden-Baden Köln, S. 76–82Google Scholar
  13. 13.
    Naruszewicz M, Mirkiewicz E, Klosiewicz-Latoszek L (1989) Atherosclerosis 79:261–265PubMedCrossRefGoogle Scholar
  14. 14.
    Ohnhaus EE, Taras E (1980) Effect of bezafibrate on platelet aggregation in healthy volunteers. In: Greten H, Lang PD, Schettler G (Hrsg.) Lipoproteins and coronary heart disease. Gerhard Witzstrock Publishers, New York Baden-Baden Köln, S. 189–191Google Scholar
  15. 15.
    Niort G, Bulgarelli A, Cassader M, Pagano G (1988) Atherosclerosis 71:113–119PubMedCrossRefGoogle Scholar
  16. 16.
    Vinazzer H, Farine JC (1983) Atherosclerosis 49:109–118PubMedCrossRefGoogle Scholar
  17. 17.
    Gugeshashvili AI, Kapanadze RV, Cheishvili LD (1986) Soobshch Akad Nauk Gruz SSR 124:181–184Google Scholar
  18. 18.
    Abshagen U, Balok W, Koch K, Lang PD, Schmidt HAE, Senn M, Stork H (1979) Eur J Clin Pharmacol 16:31–38PubMedCrossRefGoogle Scholar
  19. 19.
    Abshagen U, Spörl-Radun S, Marinow J (1980) Eur J Clin Pharmacol 17:305–308PubMedCrossRefGoogle Scholar
  20. 20.
    Klotz U (1984) Klinische Pharmakokinetik. Gustav Fischer Verlag, Stuttgart New York, S. 111Google Scholar
  21. 21.
    Wechsler JG, Hutt V, Klör HU, Bode G, Ditschuneit H (1982) Klin Wochenschr 60:97–105PubMedCrossRefGoogle Scholar
  22. 22.
    Wahl P,Hallacher C, Lang PD, Vollmar J (1978) Dtsch med Wochenschr 103:1.233–1.237CrossRefGoogle Scholar
  23. 23.
    Wheeler KAH, West RJ, Lloyd JK, Barley J (1985) Arch Dis Child 60:34–37PubMedCrossRefGoogle Scholar
  24. 24.
    Eriksson M, Angelin B (1987) Eur J Clin Invest 17:396–401PubMedCrossRefGoogle Scholar
  25. 25.
    Zimmermann R, Hoffrichter A, Walter E, Ehlers W, Andrassy K, Lang PD, Schlierf G, Weber E, Barth P (1977) Dtsch med Wochenschr 102:509–512PubMedCrossRefGoogle Scholar
  26. 26.
    Eisenberg S, Gavish D, Kleinmann Y (1986) Bezafibrate. In: Pharmacological control of hyperlipidaemia, J R Prous Science Publishers, New York, S. 145–169Google Scholar
  27. 27.
    Heckers H (1983) Med Welt 34:1.066–1.067Google Scholar
  28. 28.
    Watanabe T, Horie S, Yamada J, Isaji M, Nishigaki T, Naito J, Suga T (1989) Biochem Pharmacol 38:367–371PubMedCrossRefGoogle Scholar
  29. 29.
    Bronfman M, Orellana A, Morales MN, Bieri F, Waechter F, Streubli W, Bentley P (1989) Biochem Biophys Res Commun 159:1.026–1.031CrossRefGoogle Scholar
  30. 30.
    Fahimi HD, Reinicke A, Sujatta M, Yokoto S, Özel M (1982) Ann New York Acad Sci 386:111–135CrossRefGoogle Scholar

Bj

  1. 1.
    Mar 29, S. 1.547Google Scholar
  2. 2.
    Negwer M (1987) Organicchemical Drugs and their Synonyms, Akademie-Verlag, BerlinGoogle Scholar

vB

  1. 1.
    Lackner TE, Clissold SP (1989) Drugs 38:204–225PubMedCrossRefGoogle Scholar
  2. 2.
    Vanden-Bossche H, Marichal P, Gorrens J, Coene MC, Willemsens G, Bellens D, Roe Is I, Moereels H, Janssen PA (1989) Mycoses 32(Suppl. l):35–52PubMedGoogle Scholar
  3. 3.
    Berg D, Regel E, Harenberg HE, Plempel M (1984) Arzneim Forsch 34:139–146Google Scholar
  4. 4.
    Patzschke K, Ritter W, Siefert HM, Weber H, Wegner LA (1983) Arzneim Forsch 33:745–750Google Scholar
  5. 5.
    Nolting A, Stettendorf S, Ritter W (1986) New trends in the treatment of onychomycosis. In: Hay RJ (Hrsg.) Advances in topical antifungal therapy, Springer Verlag, Berlin, S. 108–113CrossRefGoogle Scholar
  6. 6.
    Saffe F (1986) Bifonazole in dermatological practice: result of a multicentre study. In Hay RJ (Hrsg.) Advances in topical antifungal therapy, Springer Verlag, Berlin,S. 53–64CrossRefGoogle Scholar

ST/st

  1. 1.
    Buddecke E (1977), Grundriß der Biochemie, 5. Auflage, Verlag W de Gruyter, BerlinGoogle Scholar
  2. 2.
    Schormüller J (1965), Lebensmittelchemie , Springer Verlag, Berlin, Heidelberg, New YorkGoogle Scholar
  3. 3.
    Dibbern HW, UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor, AulendorfGoogle Scholar

SH

  1. 1.
    Bäßler KH, Grühn E, Loew D, Pietrzik K (1992) Vitamin-Lexikon, Fischer, StuttgartGoogle Scholar
  2. 2.
    Friedrich W (1987) Biotin. In: Friedrich W (Hrsg.) Handbuch der Vitamine, Urban & Schwarzenberg, München Wien BaltimoreGoogle Scholar
  3. 3.
    Monographie Biotin, Bundesanzeiger vom 10.08. 1989Google Scholar

KP

  1. 1.
    US Pat 2789110 (Knoll, ert. 1957), zit. nach CA (1957) 51:15604iGoogle Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, LondonGoogle Scholar

PA

  1. 1.
    Cedarbaum JM, Schleifer LS (1990) Drugs for Parkinson’s disease, spasticity, and acute muscle spasm. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s the pharmacological basis of therapeutics. 8. Aufl., Pergamon Press, New York, S.463–484Google Scholar
  2. 2.
    Jurna I (1987) Antiparkinsonmittel, Pharmakotherapie des Morbus Parkinson und parkinsonähnlicher Symptome. In: Forth W, Henschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie, 5. Aufl., Bibliographisches Institut & F.A. Brockhaus, Mannheim, S. 519–521Google Scholar
  3. 3.
    Huber M (1988) Dtsch Med Wschr 113:992–998PubMedCrossRefGoogle Scholar
  4. 4.
    Mar 29 S. 528Google Scholar
  5. 5.
    Product information Akineton® (1984) Physician Desk Reference, 38. Aufl., Medical Econimics Company Inc at Oradell, NJ, S.1037Google Scholar
  6. 6.
    Scheid W (1983) (Hrsg.) Lehrbuch der Neurologic Thieme, Stuttgart, 5. Aufl., S. 662–670Google Scholar
  7. 7.
    Rohen JW (1978) Funktionelle Anatomie des Nervensystems, 3. Aufl., Schattauer, StuttgartGoogle Scholar
  8. 8.
    Cedarbaum JM (1987) Clin Pharmacokinet 13:141–178PubMedCrossRefGoogle Scholar
  9. 9.
    Grimaldi R, Perucca E, Ruberto G et al. (1986) Eur J Clin Pharmacol 29:735–737PubMedCrossRefGoogle Scholar
  10. 10.
    Quinn NP (1984) Drugs 28:236–262PubMedCrossRefGoogle Scholar
  11. 11.
    Parkes JD (1981) Drugs 21:341–353PubMedCrossRefGoogle Scholar
  12. 12.
    Nürnberg E, Nürnberg B (1991) Beschleunigte Freigabe, Wirkungsverstärkung. In: Nürnberg E, Surman P (Hrsg.) Hagers Handbuch der pharmazeutischen Praxis, 5. Aufl., Bd.2, Springer, Heidelberg, S.840–856Google Scholar

NB

  1. 1.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs. Pharmaceutical Press, LondonGoogle Scholar

PA

  1. 1.
    Hirsch B (1890) Chem Ber 23:3.705–3.710Google Scholar
  2. 2.
    Lüttringhaus A, von Sääf G (1939) Liebigs Ann 542:241CrossRefGoogle Scholar
  3. 3.
    Gilman H, Esmay DL (1953) J Am Chem Soc 75:2.947–2.949Google Scholar

MS

  1. 1.
    Wallhäußer KH (1988) Praxis der Sterilisation Desinfektion-Konservierung, 4. Aufl., Thieme Verlag, Stuttgart, 512–513Google Scholar
  2. 2.
    Harke HP (1982) GIT-Labor Medizin 5:35–36Google Scholar
  3. 3.
    Young BR (1974) GB 1.417.117Google Scholar
  4. 4.
    Eggensperger H, Harke HP, Bücklers L, Diehl KH, Eigener U (1982) DE 3117,792Google Scholar
  5. 5.
    Reitz RH, Fox TR, Quast JF, Hermann EA, Watanabe PG (1983) Chem Biol Interactions 43:99–119CrossRefGoogle Scholar
  6. 6.
    BoutwellRK,BoschDK(1959) Cancer Res 19:413–424PubMedGoogle Scholar
  7. 7.
    Beilfuß W, Bücklers L, Eigener U, Harke HP, Sturm U (1987) Phenole. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Antibakterielle, antifungielle und antivirale Antiseptikausgewählte Wirkstoffe, Handbuch der Antiseptik, Bd. II/3, Volk und Gesundheit, Berlin S. 315–317Google Scholar
  8. 8.
    NIOSH (1982) Registry of Toxic Effects of Chemical Substances, Bd 1 und 2, Cincinnati, OhioGoogle Scholar
  9. 9.
    Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 354–356Google Scholar

ak

  1. 1.
    Schultz OE, Geller L, Arch Pharm Ber Dtsch Pharmaz Ges (1955) 288:234CrossRefGoogle Scholar
  2. 2.
    Ali SL (1979) Fresenius Z Anal Chem 299:124–126CrossRefGoogle Scholar
  3. 3.
    Patrunky M, Wollmann H (1978) Zentralbl Pharm Pharmakother Laboratoriumsdiagn 117:959–963Google Scholar
  4. 4.
    Grimm W, Hugger JP, Neugebauer I (1973) Pharm Ind 35:733–737Google Scholar

hh

  1. 1.
    Jauch R, Hankwitz R, Beschke K, Pelzer H (1975) Arzneim Forsch 25:1.796–1.800Google Scholar
  2. 2.
    Ewe K, Hölker B (1974) Klin Wochenschr 52:827–833PubMedCrossRefGoogle Scholar
  3. 3.
    Forth W, Baldauf J, Rummel W (1963) Naunyn-Schmiedeberg’s Arch Pharmacol 246:91Google Scholar
  4. 4.
    Saunders DR, Sillery J, Rachmilewitz D, Rubin CE, Tytgat GN (1977) Gastroenterology 72:849–856PubMedGoogle Scholar
  5. 5.
    Rachmilewitz D, Karmeli F, Okon E (1980) Dig Dis Sci 25:602–608PubMedCrossRefGoogle Scholar
  6. 6.
    Schreiner J, Nell G, Löschke K (1980) Naunyn-Schmiedeberg’s Arch Pharmacol 313:249–255CrossRefGoogle Scholar
  7. 7.
    Farack UM, Nell G, Rummel W (1983) Naunyn-Schmiedeberg’s Arch Pharmacol 324:70–74CrossRefGoogle Scholar
  8. 8.
    Leng-Peschlow E (1989) Pharmacology 38:310–318PubMedCrossRefGoogle Scholar
  9. 9.
    Beubler E, Juan H (1978) Experientia 34:386–387PubMedCrossRefGoogle Scholar
  10. 10.
    Ewe K (1987) Digestion 37:247–253PubMedCrossRefGoogle Scholar
  11. 11.
    Farack UM, Nell G (1984) Digestion 30:191–194PubMedCrossRefGoogle Scholar
  12. 12.
    Karbach U, Wanitschke R (1984) Naunyn-Schmiedeberg’s Arch Pharmacol 327:336–341CrossRefGoogle Scholar
  13. 13.
    Mitznegg P, Schubert E, Domschke W, Strunz U, Domschke S, Schwemmle K, Demling L, Heim F (1975) Klin Wochenschr 53:493–495PubMedCrossRefGoogle Scholar
  14. 14.
    Roth W (1988) Arzneim Forsch 38:570–574Google Scholar
  15. 15.
    Hillestad B, Sund RB, Buajordet M (1982) Acta Pharmacol Toxicol 51:388–394CrossRefGoogle Scholar
  16. 16.
    Sund RB, Hillestad B (1982) Acta Pharmacol Toxicol 51:377–387CrossRefGoogle Scholar
  17. 17.
    Sund RB, Roland M, Kristiansen S, Salvesen B (1982) Acta Pharmacol Toxicol 50:50–57CrossRefGoogle Scholar
  18. 18.
    Sund RB, Songedal K, Harestad T, Salvesen B, Kristiansen S (1981) Acta Pharmacol Toxicol 48:73–80CrossRefGoogle Scholar
  19. 19.
    Fork F-T, Ekberg O, Nilsson G, Rerup C, Skinhoj A (1982) Gastrointest Radiol 7:383–389PubMedCrossRefGoogle Scholar
  20. 20.
    Mar 29, S. 1078Google Scholar
  21. 21.
    Gilman AG, Rall TW, Nies AS, Taylor P (1990) Goodman and Gilman’s The pharmacological basis of therapeutics, 8. Aufl., Pergamon, New York, S. 921Google Scholar
  22. 22.
    Ammon HPT (1981) Arzneimittelneben-und Wechselwirkungen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 382Google Scholar
  23. 23.
    Botzier R, Ritter U (1982) Leber Magen Darm 12:255–257Google Scholar
  24. 24.
    Rijk MC, van Hogezand RA, van Schaik A, van Tongeren JH (1989) Scand J Gastroenterol 24:1.179–1.185CrossRefGoogle Scholar
  25. 25.
    Beubler E (1985) J Pharm Pharmacol 37:131–133PubMedCrossRefGoogle Scholar
  26. 26.
    Moreto M, Planas JM, Naftalin RJ (1981) Biochim Biophys Acta 648:215–224PubMedCrossRefGoogle Scholar
  27. 27.
    Heizer WD, Warshaw AL, Waldman TA, Laster L (1968) Ann Int Med 68:839PubMedCrossRefGoogle Scholar
  28. 28.
    Meisel JL, Bergman D, Graney D, Saunders DR, Rubin CE (1977) Gastroenterology 72:1.274–1.279Google Scholar
  29. 29.
    Saunders DR, Haggitt RC, Kimmey MB, Silverstein FE (1990) Gastrointest Endoscop 36:101–104CrossRefGoogle Scholar

PK

  1. 1.
    Krüger J, Winkler P, Lüderitz E, Lück M (1985) Bismuth, Bismuth Alloys, and Bismuth Compounds. In: Gerhartz W (Hrsg.) Ullmann’s Encyclopedia of Industrial Chemistry, 5. Aufl, Bd. A4, VCH Verlagsgesellschaft, Weinheim, S. 171ffGoogle Scholar

ws

  1. 1.
    Krüger J, Winkler P, Lüderitz E, Lück M (1985), Bismuth, Bismuth Alloys, and Bismuth Compounds. In: Gerhartz W (Hrsg.) Ullmann’s Encyclopedia of Industrial Chemistry, 5. Aufl., Bd A4, VCH Verlagsgesellschaft, Weinheim, S. 185Google Scholar
  2. 2.
    Gmelin’s Handbuch der Anorganischen Chemie (1927), Bismut, System-Nr. 19,8. Aufl., Verlag Chemie, Weinheim, S.178fGoogle Scholar

WS

  1. 1.
    Warren Jr. (1983) Lancet 1:1.273Google Scholar
  2. 2.
    McNulty CAM, Dent J, Wise R (1985) Antimicrob Agents Chemother 28:837–838PubMedCrossRefGoogle Scholar
  3. 3.
    Wieriks J, Hespe W, Jaitly KD, Koekkoek PH, Lavy U (1982) Scan J Gastroenterol 17(Suppl. 80): 11–16Google Scholar
  4. 4.
    Stiel D, Peters TJ (1983) Proc Austr Soc Med Res 16:18Google Scholar
  5. 5.
    Hall DWR, van de Hoven WE (1987) Arch Int Pharmacodyn Ther 286:308–319PubMedGoogle Scholar
  6. 6.
    Crampton Jr., Gibbons LC, Rees WDW (1986) Scan J Gastroenterol 21(Suppl. 125):113–116CrossRefGoogle Scholar
  7. 7.
    Lee SP (1982) Scan J Gastroenterol 17(Suppl.80):17–21Google Scholar
  8. 8.
    Lee SP (1981) Res Commun Chem Pathol Pharmacol 34:359–364PubMedGoogle Scholar
  9. 9.
    Hamilton I, Worsley BW, O’Connor HJ, Axon ATR (1983) Gut 24:1.148–1.151 Lee SP, Lim TH, Pybus J, Clarke AC (1980) Clin Exp Pharmacol Phydiol 7:319–324Google Scholar
  10. 10.
    Bader JP (1987) Digestion 37(Suppl.2):53–59PubMedCrossRefGoogle Scholar
  11. 12.
    Gavey CJ, Szeto ML, Nwokolo CU, Sercombe J, Pounder RE (1989) Aliment Pharm Therap 3:21–28CrossRefGoogle Scholar
  12. 13.
    Nwokolo CU, Gavey CJ, Smith JTL, Pounder RE (1989) Aliment Pharm Therap 3:29–39CrossRefGoogle Scholar
  13. 14.
    Wagstaff AJ, Benfield P, Monk JP (1988) Drugs 36:132–157PubMedCrossRefGoogle Scholar
  14. 15.
    Slikkerveer A, de Wolff FA (1989) Med Toxicol Adverse Drug Exp 4:303–323PubMedCrossRefGoogle Scholar

Wb

  1. 1.
    Beyer KH, Grobosch T, Baudisch H (1990) Pharm Ztg 135:36–10Google Scholar
  2. 2.
    Serfontain WJ, Mekel R (1979) Res Comm chem Path Pharm 26:391–411Google Scholar
  3. 3.
    Buge A, Rancurd G, Posson M, Dechy H (1974) Nouv Presse Med 3:2.315–2.320Google Scholar
  4. 4.
    Burns R, Thomas DW, Barrow VJ (1974) Brit Med J 1:220–223PubMedCrossRefGoogle Scholar
  5. 5.
    Martin-Bouyer G, Foulon G, Guerbois H, Barin C (1981) Clin Toxicol 18:1.277–1.283CrossRefGoogle Scholar
  6. 6.
    Krüger G, Thomas DJ, Weinhardt F, Hoyer S (1976) Lancet I:485–487CrossRefGoogle Scholar
  7. 7.
    American Medical Association (1971) A.M. Drug Evaluations, ChicagoGoogle Scholar
  8. 8.
    Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 115Google Scholar

ak

  1. 1.
    Gmelin’s Handbuch der Anorganischen Chemie (1964) Bismut Erg.Bd., System Nr. 19, 8. Aufl., Verlag Chemie, Weinheim, S.657Google Scholar
  2. 2.
    Pohloudek-Fabini R, Friedrich F (1960) Pharm Zentralhalle 99:229Google Scholar

WS

  1. 1.
    Mar 29, S. 1.548Google Scholar

vB

  1. 1.
    Mar 29, S. 1.078Google Scholar

vB

  1. 1.
    BAz, Nr.213 vom 11.11.1989Google Scholar

GS

  1. 1.
    BAz, Nr. 109a vom 16.06.1987Google Scholar

GS

  1. 1.
    BAz, Nr. 190a om 10.10.1985 QSGoogle Scholar
  2. 1.
    Jonas R, Becker KH, Enenkel HJ, Minck K, Schliep HJ (Merck Patent GmbH) DBP 2, 645, 710 (1978, 1976), zit. nach CA (1978) 89:42759xGoogle Scholar
  3. 2.
    Kirchlechner R, Jonas R (Merck Patent GmbH) DBP 3,205,457 (1983, 1982), zit. nach CA (1983) 99: 194947bGoogle Scholar

ME

  1. 1.
    Lancaster SG, Sorkin EM (1988) Drugs 36:256–285PubMedCrossRefGoogle Scholar
  2. 2.
    Mauz ABM, Pelzer H (1990) J Cardiovasc Pharmacol 15:421–427PubMedCrossRefGoogle Scholar
  3. 3.
    Wellstein A, Palm D, Belz GG (1986) J Cardiovasc Pharmacol 8 (Suppl. 11):36–40Google Scholar
  4. 4.
    PrichardBNC(1987) Eur Heart J8(Suppl.M):121–129PubMedCrossRefGoogle Scholar
  5. 5.
    Cruickshank JM, Prichard BNC (1987) Profiles of some beta-blockers and beta-receptor stabilisers (cardiostabilisers). In: Cruickshank JM, Prichard BNC (Hrsg.) Beta blockers in Clinical Practice, Churchill, Livingstone, S. 925–981Google Scholar

PH

  1. 1.
    Drug Fut (1976) 1:454Google Scholar
  2. 2.
    Corrigan Jr., Langermann M, Moore ML (1949) J Am Chem Soc 71:530CrossRefGoogle Scholar
  3. 3.
    Philion RE (Sterling Drug, Inc) (1986) U S US 4:614,830, zit. nach CA (1987) 106:4.679hGoogle Scholar
  4. 4.
    Tullar BF, Minatoya H, Lorenz RR (1976) J Med Chem 19:834PubMedCrossRefGoogle Scholar
  5. 5.
    Ohta Pharmaceutical Co, Ltd (1983) Jpn Kokai Tokkyo Koho JP 58:134,059, zit. nach CA (1983) 99:212.291qGoogle Scholar
  6. 6.
    Otha Pharmaceutical Co, Ltd (1983) Jpn Kokai Tokkyo Koho JP 58:203,950, zit. nach CA (1983) 100: 156.372sGoogle Scholar
  7. 7.
    Ohta Pharmaceutical Co, Ltd (1983) Jpn Kokai Tokkyo Koho Jp 58:134,060, zit. nach CA (1984) 99: 212.269pGoogle Scholar
  8. 8.
    Portmann GA, Brown NH (1979) Drug Dev Ind Pharm 5:1CrossRefGoogle Scholar

RE

  1. 1.
    Kelly HW (1985) Clinical Pharmacy 4:393–403PubMedGoogle Scholar
  2. 2.
    Nathan RA, Bodman SF, Storms WW, Mingo TS (1986) Am Allergy 56:494–499Google Scholar
  3. 3.
    Friedel HA, Brogden RN (1987) Drugs 35(Suppl.3):22–41Google Scholar
  4. 4.
    Aimoto T, Ito O, Kimura R (1979) Xenobiotica 9:173–180PubMedCrossRefGoogle Scholar

SZ

  1. 1.
    Tullar BF, Minatoya H, Lorenz RR (1976) J Med Chem 19:834PubMedCrossRefGoogle Scholar
  2. 2.
    Drug Fut (1976) 1:454Google Scholar
  3. 3.
    Wilson TD (1987) J Chromatogr 391:409PubMedCrossRefGoogle Scholar
  4. 4.
    John PM, Minatoya H, Rosenberg FJ (1979) J Pharm Sci 68:475PubMedCrossRefGoogle Scholar

RE

  1. 1.
    Aoyagi Y, Katano K, Suguna H, Primeau J, Chang LH, Hecht SM (1982) J Am Chem Soc 104:5537–5538CrossRefGoogle Scholar
  2. 2.
    Takita T, Umezawa Y, Saito S, Morishima H, Naganawa H, Umezawa H, Tsuchiya T, Miyake T, Kageyama S, Umezawa S, Muraoka Y, Suzuki M, Otsuka M, Narita M, Kobayashi S, Ohno M (1982) Tetrahedron Lett 23:521–524CrossRefGoogle Scholar
  3. 3.
    Saito S, Umezawa Y, Yoshioka T, Takita T, Umezawa H (1983) J Antibiotics 36:92–95CrossRefGoogle Scholar
  4. 4.
    Baran EJ, Etcheverry SB (1983) Acta Farmaceutica Bonaerense 2:91–95, zit. nach CA (1984) 101:216326nGoogle Scholar
  5. 5.
    Fiedler HP, Wachter J (1991) J Chromatogr 536:343–347PubMedCrossRefGoogle Scholar
  6. 6.
    Thomas AH, Newland P, Sharma NR (1984) J Chromatogr 291:219–230CrossRefGoogle Scholar

WM

  1. 1.
    Ono T, Miyaki M, Taguchi T, Ohashi M (1976) Prog Biochem Pharmacol 11:48–58PubMedGoogle Scholar
  2. 2.
    Müller WE, Zahn RK (1976) Prog Biochem Pharmacol 11:28–47PubMedGoogle Scholar
  3. 3.
    Müller WE, Zahn RK (1977) Prog Nucleic Acid Res Mol Biol 20:21–57PubMedCrossRefGoogle Scholar
  4. 4.
    Vig BK, Lewis R (1978) Mutat Res 55:121–145PubMedCrossRefGoogle Scholar
  5. 5.
    Sakai TT, Riordan JM, Kumar NG, Haberle FJ, Elgavish GA, Glickson JD, Levy A (1983) J Biomol Struct Dyn 1:809–827PubMedCrossRefGoogle Scholar
  6. 6.
    Antholine WE, Kalyanaraman B, Petering DH (1985) Environ Health Perspect 64:19–35PubMedCrossRefGoogle Scholar
  7. 7.
    Sikic BI (1986) Cancer Surv 5:81–91PubMedGoogle Scholar
  8. 8.
    Favaudon V (1982) Biochimie 64:457–475PubMedCrossRefGoogle Scholar
  9. 9.
    Bus JS, Gibson JE (1984) Environ Health Perspect 55:37–46PubMedCrossRefGoogle Scholar
  10. 10.
    Hecht SM (1986) Fed Proc 45:2.784–2.791Google Scholar
  11. 11.
    Petering DH, Byrnes RW, Antholine WE (1990) Chem Biol Interact 73:133–182PubMedCrossRefGoogle Scholar
  12. 12.
    Ota K, Goto T, Fukushima M, Ariyoshi Y (1982) Gan To Kagaku Ryoho 9:1.352–1.361Google Scholar
  13. 13.
    Umezawa H (1974) Fed Proc 33:2.296–2.302Google Scholar
  14. 14.
    Hickson ID, Davies SL, Davies SM, Robson CN (1990) Int J Radiat Biol 58:561–568PubMedCrossRefGoogle Scholar
  15. 15.
    Fujita H (1971) Jap J Clin Oncol 12:151–162Google Scholar
  16. 16.
    Crooke ST, Prestayko AW, Strong JE (1978) Recent advances in the study of clinical pharmacology of bleomycin. In: Pinedo HM (Hrsg.) Clinical Pharmacology of Anti-Neoplastic Drugs, Elsevier/North-Holland, Biomedical Press, S. 225–244Google Scholar
  17. 17.
    Morantz RA, Kimler BF, Vats TS, Henderson SD (1983) J Neurooncol 1:249–255PubMedCrossRefGoogle Scholar
  18. 18.
    Sebti SM, Lazo JS (1988) Pharmacol Ther 38:321–329PubMedCrossRefGoogle Scholar
  19. 19.
    Ranfaing J, Guillier M, Simon Rigaud ML, Banzet ML, Ledoux A (1977) Poumon Coeur 33:117–122PubMedGoogle Scholar
  20. 20.
    Ruckdeschel JC (1988) Semin Oncol 15 (Suppl 3):24–28PubMedGoogle Scholar
  21. 21.
    Ostrowski MJ (1989) J Surg Oncol Suppl 1:7–13PubMedCrossRefGoogle Scholar
  22. 22.
    Campbell BJ (1986) Prim Care 13:465–476PubMedGoogle Scholar
  23. 23.
    Wannenmacher M, Esser E, Schumann J (1975) Strahlentherapie 149:131–140PubMedGoogle Scholar
  24. 24.
    Soreide O, Janssen CW Jr., Kvam G, Hartreit F (1976) Scand J Thorac Cardiovasc Surg 10:79–84PubMedCrossRefGoogle Scholar
  25. 25.
    Matthiessen W (1978) Verminderte Strahlentoleranz des Lungengewebes unter kombinierter Bleomycin-Betatronbestrahlung des differenzieten bronchogenen Plattenepithelkarzinoms. In: Forschbach G (Hrsg.) Fortbildung in Thoraxkrankheiten, Hippokrates, Stuttgart, Bd. 8, S. 83–97Google Scholar
  26. 26.
    Weiss RB, Muggia FM (1980) Am J Med 68:259–266PubMedCrossRefGoogle Scholar
  27. 27.
    Silberstein EB (1976) Am J Med 60:226–237PubMedCrossRefGoogle Scholar
  28. 28.
    Jones SE (1977) Ric Clin Lab 7:143–159PubMedGoogle Scholar
  29. 29.
    Nieweg OE, Beekhuis H, Piers DA, Sluiter HJ, Van der Wal AM, Woldring MG (1984) Cancer 53:1.675–1.681CrossRefGoogle Scholar
  30. 30.
    Levi RL, Chiarillo S (1980) Oncology 37:316–317CrossRefGoogle Scholar
  31. 31.
    Weiss RB, Bruno S (1981) Ann Intern Med 94:66–72PubMedCrossRefGoogle Scholar
  32. 32.
    Rosenfelt F, Palmer J, Weinstein I, Rosenbloom B (1982) Yale J Biol Med 55:529–531PubMedGoogle Scholar
  33. 33.
    Gardner G, Mesler D, Gitelman HJ (1989) Ren Fail 11:133–137PubMedCrossRefGoogle Scholar
  34. 34.
    Fields SM, Lindley CM (1989) DICP 23:582–588PubMedGoogle Scholar
  35. 35.
    Doll DC, Ringenberg QS, Yarbro JW (1986) J Clin Oncol 4:1.405–1.417Google Scholar
  36. 36.
    Van Barne veld PWC, Sleijfer DT, Van Der Mark TW, Mulder NH, Schraffordt Koops H, Sluiter HJ, Peset R (1987) Amer Rev Resp Dis 135:48–51Google Scholar
  37. 37.
    Van Barne veld PWC, Van Der Mark TW, Sleijfer DT, Mulder NH, Schraffordt Koops H, Sluiter HJ, Peset R (1984) Amer Rev Resp Dis 130:1.078–1.081Google Scholar
  38. 38.
    Cohen MB, Austin JH, Smith Vaniz A, Lutzky J, Grimes MM (1989) Am J Clin Pathol 92:101–104PubMedGoogle Scholar
  39. 39.
    Santrach PJ, Askin FB, Wells RJ, Azizkhan RG, Merten DF (1989) Cancer 64:806–811PubMedCrossRefGoogle Scholar
  40. 40.
    Adamson IY (1984) Environ Health Perspect 55:25–36PubMedCrossRefGoogle Scholar
  41. 41.
    Kiefer O (1973) Dermatologica 146:229–243PubMedCrossRefGoogle Scholar
  42. 42.
    Speit G, Hochsattel R, Vogel W (1984) Basic Life Sci 29 Pt A:229–244PubMedGoogle Scholar
  43. 43.
    Obe G, Matthiessen W, Göbel D (1981) Mutation Res 81:133–141PubMedCrossRefGoogle Scholar
  44. 44.
    Ma T (1982) Mutat Res 99:257–271PubMedCrossRefGoogle Scholar
  45. 45.
    Jackson RM (1985) Chest 88:900–905PubMedCrossRefGoogle Scholar
  46. 46.
    Trynka AF, Godleski JJ, Brain JD (1984) Cancer Treat Rep 68:759–764Google Scholar
  47. 47.
    Hulbert JC, Grossman JE, Cummings KB (1983) J Urol 130:163–164PubMedGoogle Scholar
  48. 48.
    Rodin SM, Johnson BF (1988) Clin Pharmacokinet 15:227–244PubMedCrossRefGoogle Scholar

  1. 1.
    Buchbauer G, Spreitzer H, Frei H (1991) Pharmazie 46:161–170Google Scholar
  2. 2.
    Foerst W (1966) Terpentinölprodukte bis Uran und -Verbindungen. In: Ullmanns Encyklopädie der technischen Chemie, Bd. 17, Urban & Schwarzenberg, München Berlin Wien, S.35–36Google Scholar

ak

  1. 1.
    Mar 29, S. 1066Google Scholar
  2. 2.
    Müller A (1941) Die physiologischen und pharmakologischen Wirkungen der ätherischen Öle, Riechstoffe und verwandten Produkte, 2. Aufl., Hüthig, HeidelbergGoogle Scholar

Gs

  1. 1.
    DRP 175 097, ref. Hagers Handbuch der pharmazeutischen Praxis (1930) Bd. 1, S.210Google Scholar

  1. 1.
    Müller A (1941) Die physiologischen und pharmakologischen Wirkungen der ätherischen Öle, Riechstoffe und verwandten Produkte, 2. Aufl., Hüthig, HeidelbergGoogle Scholar

Gs

  1. 1.
    Křepinsky J, Herout V, Šorm F (1959), Coll Czech Chem Commun 24:1884–1886Google Scholar

  1. 1.
    Krepinsky J, Herout V, Šorm F (1959) Coll Czech Chem Commum 24:1884–1886Google Scholar
  2. 2.
    Beil Hauptwerk, Bd. 6, S. 83Google Scholar
  3. 3.
    Beil Erg. Werk 2, Bd. 6, S. 85Google Scholar

Mw

  1. 1.
    Schindler H (1957) Arzneim Forsch 7:747–750Google Scholar
  2. 2.
    Betts TJ (1990) J Chromatogr 511:373–378CrossRefGoogle Scholar
  3. 3.
    Pietta P et al (1988) J Chromatogr 457:442–445CrossRefGoogle Scholar
  4. 4.
    Van Hulle C et al (1983) J Pharm Belg 38(2):97–100Google Scholar
  5. 5.
    Nunez-Vergara LJ, Squella JA, Berrios-Sagredo EA (1983) Farmaco, Ed Prat 38(5):219–226Google Scholar
  6. 6.
    Gorecki P, Otta H (1979) Herba Pol 25(4):285–291Google Scholar
  7. 7.
    Quercia V, Bucci B, Iela G, Terracciano M, Pierini N (1978) Boll Chim Farm 117(9):545–548PubMedGoogle Scholar
  8. 8.
    Gurkan T (1976) Mikrochim Acta 1(2–3):173–180CrossRefGoogle Scholar
  9. 9.
    Fleischmann L, Maffi G, Mezzanzanica PG (1975) Boll Chim Farm 114(9):534–538PubMedGoogle Scholar
  10. 10.
    Di Renzo N (1972) Boll Chim Farm 111(7):450–453PubMedGoogle Scholar
  11. 11.
    Seiles FE, Talavera GE (1972) Galen Acta 23(1–2):49–69Google Scholar
  12. 12.
    Quercia V, Cavazzuti G, Merli F (1970) Fitoterapia 41(l):34–39Google Scholar
  13. 13.
    Genest K, Hughes DW (1968) Can J Pharm Sci 3(4):84–90Google Scholar
  14. 14.
    De Lorenzi F, Fontani F, Morandini F (1969) Boll Chim Farm 108(2):93–99PubMedGoogle Scholar
  15. 15.
    Borkowski B, Sobiczewska M (1968) Herba Pol 14(1–2):35–37Google Scholar
  16. 16.
    Rodriguez HB (1967) SAFYBI 7(23):220–229Google Scholar
  17. 17.
    Wachsmuth H, van Koeckhoven L (1967) J Pharm Belg 22(7–8):315–316PubMedGoogle Scholar

Rj

  1. 1.
    Mar29,S.979Google Scholar
  2. 2.
    Lévy-Appert-Collin MC, Lévy J (1977) J Pharm Belg 32:13–22PubMedGoogle Scholar
  3. 3.
    Magistretti MJ (1980) Fitoterapia 51:67–69Google Scholar
  4. 4.
    Peeples A, Dalvi RR (1982) J Appl Toxicol 2:300–302PubMedCrossRefGoogle Scholar
  5. 5.
    Dalvi RR, Peeples A (1981) J Pharm Pharmacol 33:51–53PubMedCrossRefGoogle Scholar

BJ

  1. 1.
    Klavehn W, Kraft H (Knoll AG) DP Pat. 1044809 (Knoll, ert. 1958), zit. nach CA (1961) 55:17545bGoogle Scholar

PA

  1. 1.
    Mar 29, S.529Google Scholar

vB

  1. 1.
    Ziegler K, Schneider K, Schneider J (1959) Liebigs Ann Chem 623:9–17CrossRefGoogle Scholar
  2. 2.
    Ziegler K (1958), Brit Pat 803178, zit. nach CA (1959) 53:6985 bGoogle Scholar
  3. 3.
    Steinegger E, Hänsel R (1988) Lehrbuch der Pharmakognosie und Phytopharmazie, Springer Verlag, Berlin, S.327CrossRefGoogle Scholar
  4. 4.
    Schwyzer J (1930) Pharm Ztg 75:1275–1276Google Scholar
  5. 5.
    Abraham RA, Barlow AP, Rowan AE (1989) Magn Res Chem 27:1074–1084CrossRefGoogle Scholar
  6. 6.
    Bohlmann F, Zeisberg R, Klein E (1975) Org Magn Res 7:426–431CrossRefGoogle Scholar

  1. 1.
    Beil Hauptwerk, Bd. 6, S.79Google Scholar
  2. 2.
    Bertram J, Walbaum H (1893) Arch Pharmaz 231:290–305CrossRefGoogle Scholar

  1. 1.
    Pistor H, Knippschild G, Meffert A, Rasch J Bor-Verbindungen, anorganische. In: Ull, Bd 8, S. 663 ffGoogle Scholar
  2. 2.
    Mitteilungen der Arzneimittelkommission der Deutschen Apotheker (1983) Dtsch Apoth Ztg 123:1.449Google Scholar

WS

  1. 1.
    Jaspersen HP, Schlumpf M (1969) Schweiz Apoth Z 107:622–630Google Scholar
  2. 2.
    Kramer A, Zbinden G, Stephan U, Koch St, Koch D, Junghans A (1985) Akute Toxizität von Antiseptika. In: Kramer A, Berencsi G, Weuffen W (Hrsg.) Toxische und allergische Nebenwirkungen von Antiseptika, Handbuch der Antiseptik, Bd. I/5, Volk und Gesundheit, Berlin, S. 113–210Google Scholar
  3. 3.
    Wallhäußer KH (1988) Praxis der Sterilisation Desinfektion-Konservierung, 4. Aufl., Thieme Verlag, Stuttgart New York, S. 488Google Scholar
  4. 4.
    Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 124–126Google Scholar

ak

  1. 1.
    Morren HG (1950) Belg Pat 497,501; CA (1955) 49:1100eGoogle Scholar
  2. 2.
    Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Auflage, The Pharmaceutical Press, LondonGoogle Scholar
  3. 3.
    EbelS (1977) Handbuch der Arzneimittel-Analytik, S.239, Verlag Chemie, Weinheim New YorkGoogle Scholar
  4. 4.
    Goenechea S (1966) Z Analyt Chem 218:416CrossRefGoogle Scholar
  5. 5.
    Rücker G (1966) Arch Pharm 299:688CrossRefGoogle Scholar
  6. 6.
    KedingH, Schmidt G (1969) Arzneim Forsch 19:342 und 666Google Scholar

RE

  1. 1.
    Yih TD, Rossum JM van (1976) Xenobiotica 6:355–362PubMedCrossRefGoogle Scholar
  2. 2.
    Philipp E, Kapp W (1983) Br J Clin Pharmacol 16:161S–165SPubMedCrossRefGoogle Scholar
  3. 3.
    Keding H, Schmidt G (1969) Arzneim Forsch 19:342–347Google Scholar
  4. 4.
    Keding H, Schmidt G (1969) Arzneim Forsch 19:666–667Google Scholar
  5. 5.
    Fischbach R (1983) Br J Clin Pharmacol 16 (Suppl 1):167S–171SPubMedCrossRefGoogle Scholar
  6. 6.
    Wolffgramm J, Lechner J, Coper H (1988) Arzneim Forsch 38:885–891Google Scholar
  7. 7.
    Sticht G, Käferstein H (1980) Z Rechtsmed 85:169–175PubMedCrossRefGoogle Scholar

Hg

  1. 1.
    Howard JW Fraser WA (1941) Org Synthese Coll Vol I:475–478Google Scholar

Et

  1. 1.
    Da Prada M, Kettler R, Keller HH, Burkard WP, Haefely WE (1989) J Neural Transm (Suppl) 28:5–20Google Scholar
  2. 2.
    Schiwy W, Heath WR, Delini-Stula A (1989) J Neural Transm (Suppl) 28:33–44Google Scholar
  3. 3.
    Amrein R, Allen SR, Guentert TW, Hartmann D, Lorscheid T, Schoerlin MP, Vranesic D (1989) Br J Psychiat 155(Suppl6):66–71Google Scholar

RM

  1. 1.
    (1926) C II:1.336Google Scholar
  2. 2.
    Graf E, Preuß R (1979) Gadamers Lehrbuch der chemischen Toxikologie und Anleitung zur Ausmittelung der Gifte Bd. I/2, 3. Aufl., Vandenhoeck & Ruprecht, GöttingenGoogle Scholar
  3. 3.
    Graf E, Preuß R (1966) Gadamers Lehrbuch der chemischen Toxikologie und Anleitung zur Ausmittelung der Gifte Bd. II, 3. Aufl., Vandenhoeck & Ruprecht, GöttingenGoogle Scholar
  4. 4.
    Kuhnert-Brandstätter M, Bachleitner-Hofmann F (1971) Arch Pharm 304:580CrossRefGoogle Scholar
  5. 5.
    Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor Aulendorf, Spektr. -Nr. 1.5 09Google Scholar
  6. 6.
    Auterhoff H, Kovar KA (1985) Identifizierung von Arzneistoffen, Wissenschaftliche Verlagsgesellschaft mbH Stuttgart, S. 268Google Scholar
  7. 7.
    Goenechea S (1966) Fresenius’ Z Anal Chem 218:416CrossRefGoogle Scholar
  8. 8.
    Avdovich HW, Neville GA (1969) Can J Pharm Sci 4:51Google Scholar
  9. 9.
    Rücker G (1966) Arch Pharm 299:688CrossRefGoogle Scholar
  10. 10.
    Doornbos DA, de Zeeuw RA (1969) Pharm Weekbl 104:233PubMedGoogle Scholar
  11. 11.
    Gill R, Stead AH, Moffat AC (1981) J Chromatogr 204:275PubMedCrossRefGoogle Scholar
  12. 12.
    Schütz H, Pielmeyer A, Weiler G (1990) Ärztl Lab 36:113Google Scholar
  13. 13.
    White PC (1980) J Chromatogr 200:271PubMedCrossRefGoogle Scholar
  14. 14.
    Daldrup T, Susanto F, Michalke P (1981) Fresenius’ Z Anal Chem 308:413CrossRefGoogle Scholar
  15. 15.
    Otto HH, Mrosek S, Weber I (1976) Dtsch Apoth Ztg 116:1785Google Scholar

RE

  1. 1.
    Koeppel C, Tenczer J, Beyer KH (1985) Arzneim Forsch 35:1.334–1.335Google Scholar

Hg

  1. 1.
    Riedel-E de Haen AG (1933) Ger 575,470, zit. nach CA (1933) 27:3559Google Scholar
  2. 2.
    Boedecker F (1930) U.S. 1, 739, 662, zit. nach CA (1930)24:919Google Scholar
  3. 3.
    Graf E, Preuß R (1979) Gadamers Lehrbuch der chemischen Toxikologie und Anleitung zur Ausmittelung der Gifte, Bd. I/2, Vandenhoeck & Ruprecht, Göttingen, S. 795Google Scholar
  4. 4.
    Chatten LG, Levi L (1957) Appl Spectr 11:177, zit. nach CA (1958) 52:7324gCrossRefGoogle Scholar
  5. 5.
    Goenechea S (1966) Fresenius’ Z Anal Chem 218:416CrossRefGoogle Scholar
  6. 6.
    Avdovich HW, Neville GA (1969) Can J Pharm Sci 4: 51Google Scholar
  7. 7.
    Doornbos DA, de Zeeuw RA (1969) Pharm Weekbl 104:233PubMedGoogle Scholar
  8. 8.
    Gill R, Stead AH, Moffat AC (1981) J Chromatogr 204:275PubMedCrossRefGoogle Scholar
  9. 9.
    Uhlmann HJ (1964) Pharm Ztg 109:1998Google Scholar
  10. 10.
    de Zeeuw RA, Feitsma MT (1966) Pharm Weekbl 101:957PubMedGoogle Scholar
  11. 11.
    de Zeeuw RA, Wijsbeek J (1969) Pharm Weekbl 104:901PubMedGoogle Scholar
  12. 12.
    White PC (1980) J Chromatogr 200:271PubMedCrossRefGoogle Scholar
  13. 13.
    Castle RN, Poe CF (1944) J Am Chem Soc 66:1440CrossRefGoogle Scholar
  14. 14.
    Rink M, Schuster G (1960) Dtsch Apoth Ztg 100:842Google Scholar

RE

  1. 1.
    Sternbach LH (1978) Proge Drug Res 22:229–266Google Scholar
  2. 2.
    Hester BJ (1986) in Berger JG (Edit) Antianxiety Drugs Wiley, Nex York 6:51–125Google Scholar
  3. 3.
    Schütz H (1982) Benzodiazepines I, Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  4. 4.
    Schütz H (1989) Benzodiazepines II, Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar

  1. 1.
    Hafely W, Kyburz E, Gerecke M, Möhler H (1985) Adv Drug Res 14:165–322Google Scholar
  2. 2.
    Greenblatt DJ, Divoll M, Abernethy DR, Ochs HR, Shader RI (1984) Benzodiazepine pharmacokinetics: an overview. In: Burrows GD, Norman TR, Davies B (Hrsg.) Antianxiety agents, Elsevier, Amsterdam, S. 79–92Google Scholar
  3. 3.
    Klotz U (1984) Progr Clin Biochem Med Vol 1:117–167CrossRefGoogle Scholar

Wm

  1. 1.
    Woods WG, Roberts JD (1957) J Org chern 22:1.124CrossRefGoogle Scholar
  2. 2.
    DAB 9 V.6.1 und V.6.2 Methode 1Google Scholar
  3. 3.
    Mynka AF, Lyuta ML (1976) Farm Zh (Kiew) 4:34Google Scholar
  4. 4.
    Sapegina LP, Brutko LI (1979) Famatsiya (Moscow) 28:55Google Scholar
  5. 5.
    Zenko IV, Progodina LI, Pertsovskii AL, Voitekhovskaya GI (1980) Vestsi Akad Navuk BSSR, Ser Khim Navuk 6:8Google Scholar

hb

  1. 1.
    Wallhäußer KH (1988) Praxis der Sterilisation Desinfektion-Konservierung, 4. Aufl., Thieme Verlag, Stuttgart New York, S.515Google Scholar
  2. 2.
    Beilfuß W, Bücklers L, Eigener U, Harke HP, Sturm U (1987) Phenole. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Antibakterielle, antifungielle und antivirale Antiseptikausgewählte Wirkstoffe, Handbuch der Antiseptik, Bd. II/3, Volk und Gesundheit, Berlin, S. 275–276Google Scholar
  3. 3.
    Schmeiß U, Süß W (1987) Halogene. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Antibakterielle, antifungielle und antivirale Antiseptik-ausgewählte Wirkstoffe, Handbuch der Antiseptik, Bd.II/3, Volk und Gesundheit, Berlin, S.189–190Google Scholar
  4. 4.
    NN (1974) Ther d Gegenw 113:274–275Google Scholar
  5. 5.
    Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 353–356Google Scholar

ak

  1. 1.
    Mar 29, S. 1.042Google Scholar
  2. 2.
    Wirth W, Gloxhuber C (1981) Toxikologie, Thieme, Stuttgart, S. 186Google Scholar

vB

  1. 1.
    Silverstein RM (1974) Anal Biochem 62:478–484PubMedCrossRefGoogle Scholar
  2. 2.
    Boyer PD (1971) The Enzymes, 3.Ed., Vol.III, 541 Academic Press, New YorkGoogle Scholar
  3. 3.
    Hennrich N (1969) Pharm Ind 31:228–235Google Scholar
  4. 4.
    Möller H (1979) Ph Ztg 124:2279–2286Google Scholar

WE

  1. 1.
    Keck J (1963) Liebigs Ann Chem 662:171CrossRefGoogle Scholar

HÄ/pb

  1. 1.
    Amin AH, Metha DR (1959) Nature 184:1317–1319PubMedCrossRefGoogle Scholar
  2. 2.
    Engelhorn R, Püschmann S (1963) Arzneim Forsch/ Drug Res 13:474–480Google Scholar
  3. 3.
    Engelhorn R, Püschmann S (1963) Naunyn-Schmiedeberg’s Arch Exp Path Pharmakol 246:54Google Scholar
  4. 4.
    Gieseking R, Baldamus U (1968) Beitr Klin Tuberk 137:1–18CrossRefGoogle Scholar
  5. 5.
    Merker HJ (1966) Arzneim Forsch/Drug Res 16:509–516Google Scholar
  6. 6.
    Bürgi H, Regli J (1967) Ther Umsch 24:116–118PubMedGoogle Scholar
  7. 7.
    Bruce RA, Kumar V (1968) Brit J Clin Pract 22:289–292PubMedGoogle Scholar
  8. 8.
    Eigelsreiter H, Mair M (1968) Arzneim Forsch/Drug Res 17:353–355Google Scholar
  9. 9.
    Renovanz HD, Keck J (1979) Prax Pneumol 33:761–768Google Scholar
  10. 10.
    Busca G, Fogliardi F, Sanchioni A, Giugliano F (1983) Clin Trials J 20:115–118Google Scholar
  11. 11.
    Rossmann H (1974) Dtsch Med Wschr 99:408–410PubMedCrossRefGoogle Scholar
  12. 12.
    Renovanz HD, Merker HJ (1973) Pneumonologie 148:125–133PubMedCrossRefGoogle Scholar
  13. 13.
    Jauch R, Hankwitz R, Maas D, Wollmann R (1975) Arzneim Forsch/Drug Res 25:1954–1958Google Scholar
  14. 14.
    Bechgarg E, Nielsen A (1982) Biopharm Drug Dispos 3:337–344CrossRefGoogle Scholar
  15. 15.
    Liebrich KG, Renovanz HD (1965) Arzneim Forsch/ Drug Res 15:305–322Google Scholar
  16. 16.
    Kjer J, Christensen F, Ryskjaer S, Arseth-Hansen P (1971) Curr Ther Res 13:434–443PubMedGoogle Scholar
  17. 17.
    Cobbin DM, Elliott FM, Rebuck AS (1971) Aust NZ J Med 1:137–140CrossRefGoogle Scholar
  18. 18.
    Hamilton WFD, Palmer KNV, Gent M (1970) Br Med J 3:260–261PubMedCrossRefGoogle Scholar
  19. 19.
    Thomson ML, Pavia D, Gregg I, Stark JE (1974) Brit J Dis Chest 68:21–27PubMedCrossRefGoogle Scholar
  20. 20.
    Ergotan F (1967) Kinderärztl Prx 35:141–146Google Scholar
  21. 21.
    Huether W (1971) Therapiewoche 21:2241–2242Google Scholar
  22. 22.
    Guslandi M (1982) Pharmacy intern 3:228–229Google Scholar

SZ

  1. 1.
    Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, AulendorfGoogle Scholar
  2. 2.
    Unveröffentlichte Ergebnisse der Firma Boehringer IngelheimGoogle Scholar
  3. 3.
    DAB 9V.6.2,Methode IIGoogle Scholar

  1. 1.
    Beilstein 3, 63; I29, II51, III 123Google Scholar
  2. 2.
    Dibbern HW (1983) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, AulendorfGoogle Scholar

EK

  1. 1.
    Senoh S (1951) J Pharm Soc Jap 71:798–800Google Scholar
  2. 2.
    Auterhoff H, Lang W (1970) Arch Pharm 303:49–52CrossRefGoogle Scholar

EK

  1. 1.
    Senoh S (1951) J Pharm Soc Jap 71:798–800Google Scholar
  2. 2.
    Auterhoff H, Lang W (1970) 303:49–52Google Scholar

EK

  1. 1.
    Cedarbaum JM, Schleifer LS (1990) Drugs for Parkinson’s disease, spasticity, and acute muscle spasms. In: Gillman AG, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s the pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York, S. 463–484Google Scholar
  2. 2.
    Götz C (1990) Neurology 40 (Suppl. 3):50–54Google Scholar
  3. 3.
    Quinn NP (1984) Drugs 28:236–262PubMedCrossRefGoogle Scholar
  4. 4.
    Andersen PH, Gingrich JA, Bates MD, Dearry A, Falardeau P, Senogles SE, Caron M (1990) Trends Pharmacol Sci 11:231–236PubMedCrossRefGoogle Scholar
  5. 5.
    Stroßberg AD (1991) Eur J Biochem 196:1–10CrossRefGoogle Scholar
  6. 6.
    Seeman P, Niznik HB (1990) FASEB J 4:2737–2744PubMedGoogle Scholar
  7. 7.
    Huber M (1988) Dtsch Med Wschr 113:992–998PubMedCrossRefGoogle Scholar
  8. 8.
    Scheid W (1983) (Hrsg.) Lehrbuch der Neurologie, 5.Aufl.,Thieme, Stuttgart, S. 662–670Google Scholar
  9. 9.
    Rohen JW (1978) Funktionelle Anatomie des Nervensystems, 3. Aufl., Schattauer, StuttgartGoogle Scholar
  10. 10.
    Ho KY, Thorner MO (1988) Drugs 36:67–82PubMedCrossRefGoogle Scholar
  11. 11.
    Senogles SE, Spiegel AM, Padrell E, Iyengar R, Caron MG (1990) J Biol Chem 265:4507–4514PubMedGoogle Scholar
  12. 12.
    Neumann F, Schenck B (1987) Endokrinopharmakologie, Pharmakotherapie mit Hormonen. In: Forth W, Henschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie, 5. Aufl., B.I. Wissenschaftsverlag, Mannheim, S. 396–420Google Scholar
  13. 13.
    Müller EE, Locatelli V, Cella S, Penalva A, Novelli A, Cocchi D (1983) Drugs 25:399–432PubMedCrossRefGoogle Scholar
  14. 14.
    Kuret JA, Murad F (1990) Adenohypophyseal hormo nes and related substances. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s the pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York, S. 1334–1348Google Scholar
  15. 15.
    Cedarbaum JM (1987) Clin Pharmacokin 13:141–178CrossRefGoogle Scholar
  16. 16.
    Friis ML, Paulson OB, Hertz MM (1979) Acta Neurol Scand 59:88–95PubMedCrossRefGoogle Scholar
  17. 17.
    Calne DB, Stoessl J (1986) Approaches to the use of bromocriptine in Parkinson’s disease. In: Fahn ST,Marsden CD, Jenner P, Teychenne P (Hrsg.) Recent developments in Parkinson’s disease, Raven Press, New YorkGoogle Scholar
  18. 18.
    Grimes JD, Hassan M (1983) Can J Neurol Sci 10:86–90PubMedGoogle Scholar
  19. 19.
    Parkes JD (1981) Drugs 21:341–353PubMedCrossRefGoogle Scholar

NB

  1. 1.
    Dibbern H W (1978), UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor AulendorfGoogle Scholar

SH

  1. 1.
    Soc d’Etud Scient et Indust de l’Ile France (1965), Fr 1407055; CA (1965) 63:17987–17988Google Scholar
  2. 2.
    Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia, S. 187, Noyes Publications, Park Ridge-New Jersey, USAGoogle Scholar
  3. 3.
    Daldrup T, Susanto F, Michalke P (1981) Fres Z Analyt Chem 308:413CrossRefGoogle Scholar
  4. 4.
    Masumarra G, Scarlata G, Cirma G (1985) J Chromatogr 350:151CrossRefGoogle Scholar

RE

  1. 1.
    Weihrauch TR, Kilbinger H (1982) Dtsch Med Wochenschr 107:1.323–1.328CrossRefGoogle Scholar
  2. 2.
    Sava P, Angel F, Schang JC, Grenier J (1979) Arzneim Forsch 29:799–804Google Scholar
  3. 3.
    Lux G, Engel H, Rösch W (1980) Fortschr Med 98:708–711PubMedGoogle Scholar
  4. 4.
    Fontaine HJ, Reuse J (1978) Arch Int Pharmacodyn Ther 235:51–61PubMedCrossRefGoogle Scholar
  5. 5.
    Lücker PW, Tinhof W, Wetzelsberger N, Weyers W, Brodbeck R (1983) Arzneim Forsch 33:453–458Google Scholar
  6. 6.
    Cascapride, Basisinforamtion, Merck 1982Google Scholar
  7. 7.
    Brodie RR, Chasseaud LF, Rooney L (1984) J Chromatogr 310:353–360PubMedGoogle Scholar
  8. 8.
    Mantelmacher H, Bettarello A (1978) Fortschr Med 96:2.117–2.120Google Scholar
  9. 9.
    Leisner B, Brückner WL, Luderschmidt Ch (1982) Fortschr Med 100:1.883–1.885Google Scholar
  10. 10.
    Cartsburg R, Fischer M (1980) Fortschr Med 98:679–682Google Scholar
  11. 11.
    Tymper F (1981) Fortschr Med 99:749–750Google Scholar
  12. 12.
    Leonhardt L, Gehrls D, Wiemann H (1979) Therapiewoche 29:4.337–4.342Google Scholar
  13. 13.
    Ruoff HJ (1986) Stoffe zur Ulkustherapie. In: Ammon HPT (Hrsg.) Arzneimittelneben-und Wechselwirkungen, Wissenschaftliche Verlagsgesellschaft mbH Stuttgart, S. 600–610Google Scholar
  14. 14.
    Fachinformation Cascapride, Merck 1989Google Scholar

Wb

  1. 1.
    Topart J, Hanocq M, van Damme M, Molle L (1973) J Pharm Belg 28:663Google Scholar

RE

  1. 1.
    Brannen JO, McEoy JP, Wilson WH, Petrie MW, Ban T (1981) Pharmacopsychiat 14:139–140CrossRefGoogle Scholar
  2. 2.
    Itoh H (1984) Psychopharmacol Bull 21:120–122Google Scholar
  3. 3.
    Benfield P, Ward A, Clark BG, Jue SG (1988) Drug 35:670–684CrossRefGoogle Scholar
  4. 4.
    Malfroid M, Hens RP, Dom R 81978) Acta psychiat Belgica 78:147–154Google Scholar
  5. 5.
    Niemeggers CJE, Janssen PAJ (1984) Arzneim Forsch 24:45–52Google Scholar
  6. 6.
    Dubinsky B, McGuire JL, Niemeggers CJE, Janssen PAJ, Weintraub HS (1982) Psychopharmacology 78:1–7PubMedCrossRefGoogle Scholar
  7. 7.
    Peroutka SJ, Snyder SH (1980) American J Psychiat 137:1.518–1.522Google Scholar
  8. 8.
    Richelson E (9184) J Clin Psychiat 45:331–336Google Scholar
  9. 9.
    Tischio J, Chaikin P, Abrams L, Hetyei N, Patrick J, Weintraub H, Collins D, Chasin M, Wesson D, Abuzzahab F (1982) J Clin Pharmaco l: 22,16aGoogle Scholar
  10. 10.
    van den Eeckhout E, Belpaire FM, Bogaert MG, De Moerloose P (1980) Europ J Drug Metab Pharmacokinetics 5:45–48